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ABSTRACT 
 A hallmark of the adaptive immune system in jawed vertebrates is its ability to 
generate a diverse collection of antigen receptors with numerous specificities. Such 
diversity improves species fitness by affording individuals the ability to recognize and 
clear any invading pathogen they may encounter. Humoral adaptive immunity by B cells 
generates innumerable specificities directed against native and soluble antigens. On the 
other hand, αβ T cells in cell-mediated adaptive immunity bear antigen receptors 
(TCRs) that primarily only recognize peptide fragments associated with major 
histocompatibility complex (MHC) proteins. Here, using a cellular reporter system, I 
outline how TCRs bear intrinsic specificity for MHC molecules. This specificity is weak 
by design to promote flexible interactions between the diverse components of both the 
TCR and the MHC. Yet, the specificity can be revealed by promoting conserved, 
germline interactions using coreceptors that scaffold TCR/MHC interactions. 
Furthermore, TCR specificity for MHC is preserved even upon testing reactivities of 
TCRs from other species. Altogether, the data indicate that TCR/MHC interactions are 
not coincidental but rather have been evolutionarily selected to promote efficient 
antigen recognition.   
 
The form and content of this abstract are approved. I recommend its publication. 
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A HISTORICAL INTRODUCTION 
 Self/non-self discrimination has been a major challenge for biological species in all 
domains of life. By identifying a foreign substance and eliminating it, an organism can 
survive and transmit such machinery to its progeny. Divergent evolution has led to 
varied strategies employed by organisms to determine self vs. non-self. Many bacterial 
species have evolved the CRISPR/Cas system whereby foreign DNA is incorporated 
into the host DNA to act as a catalog of all the different occasions when non-self DNA 
entered the bacterium [1]. In this manner, in any future instance when the same foreign 
DNA enters the host, this threat is recognized and neutralized immediately. 
Vertebrates, invertebrates and plants have developed pattern recognition receptors 
such as TLRs which recognize substances that are not synthesized by the host, such as 
dsRNA and components of bacterial cell walls [2]. Unique to jawed vertebrates, though, 
is an antigen-specific immune system using proteins generated by somatic DNA 
recombination [3]. B cells and T cells are the two specialized types of cells which 
undergo somatic DNA recombination to generate antigen receptors of myriad 
specificities [4]. A curiosity, though, remains because B cell antigen receptors (BCRs) 
recognize antigens in all conformational orientations while T cell antigen receptors 
(TCRs) primarily recognize linear peptide antigens presented by major 
histocompatibility complex (MHC) molecules [5, 6]. TCRs recognize antigens in this 
form both during T cell development and during an immune response, making MHC-
restriction a fundamental aspect of T cell biology. 
1.1 First efforts to understand the adaptive immune system 
 The initial observations surrounding immunity were made centuries ago. 
Previously infected individuals were observed to display greater immunity upon 
reinfection. Indeed, variolation (where uninfected individuals are infected with samples 
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obtained from an infected individual to promote protective immunity) was common in 
China and Europe by the sixteenth century [7, 8]. Edward Jenner was the first to 
recognize that infecting individuals with the related cowpox virus protected them 
against smallpox infections [9]. Louis Pasteur furthered these investigations by 
determining how to reduce the virulence of pathogens and produce attenuated 
pathogens [10]. These could serve as vaccines protecting individuals from getting 
infected if they encountered the virulent pathogen. Thus, these initial studies and 
observations highlighted two important aspects of adaptive immunity. First, various 
specificities directed at numerous pathogens exist within an individual. Second, 
immunization renders a memory within the individual to protect them upon reinfection.  
1.2 Grappling with tissue rejection 
 As studies involving immunizations and antigen specificities were ongoing, an 
interesting phenomenon was discovered in the late 1920s. In 1927, Bover identified that 
tissue transplants were not rejected between identical twins, a phenomenon he called 
homoisotransplantation [11]. These data indicated that rejection of transplanted tissues 
had a genetic basis. A few years later, pioneering studies by Peter Gorer identified a 
heritable marker in mice that he called antigen II that imparted susceptibility to tumor 
transplantation [12]. Indeed, mice lacking antigen II could not be transplanted with the 
tumor. Thus, genes linked to antigen II were important in determining the extent to 
which a transplant was tolerated (perhaps because it was considered ‘self’) or rejected 
(perhaps because it was considered ‘non-self’).  
 Many individuals during this time period were beginning to understand that from 
the host’s perspective, infection by a pathogen was as foreign as a tissue transplant. 
Thus, the major question asked by scientists was the basis for tolerance and immunity. 
Observations and experiments by Ray Owen and Peter Medawar provided evidence to 
support the notion that tolerance is imparted during ontogeny [13, 14]. Indeed, if an 
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organism is exposed to foreign substances during development, the organism will 
consider the foreign substance as ‘self’ and be tolerized to it. Concurrently, George 
Snell and Gorer bred numerous laboratory mice and created lines that differed from 
each other at specific loci implicated in tissue rejection (congenic mice) [15]. In doing 
so, they were able to identify the histocompatibility (H) genes. Since Gorer had referred 
to the locus he had previously identified as antigen II, Snell and Gorer combined the two 
names to call this the H-2 locus in mice, which is where the MHC genes are localized.  
1.3 MHC-restriction of TCRs 
 By the 1960s, it became clear that there were two distinct types of responses by 
the immune system. The first involved B cells that used antibodies to recognize their 
targets [16, 17]. Jacques Miller’s experiments in the late 1950s and early 1960s 
determined that T cells originating in the thymus represented the second arm and were 
crucial for cell-mediated immunity [18]. However, while it was known that antibodies 
recognized native antigens, how T cells recognized their targets was unclear [19]. 
 In 1974, two separate publications by Peter Doherty and Rolf Zinkernagel shed 
light on this conundrum [20, 21]. Using T cells obtained from a virus-infected mouse, 
the authors demonstrated that these T cells could only kill infected target cells when 
the target cells shared their MHC molecules with that of the initially infected mouse. In 
a subsequent publication, the authors proposed an ‘altered-self’ hypothesis for T cell 
recognition of antigen. In this scenario, virus infected cells would somehow alter the 
MHC molecules to be able to activate the T cells, which would otherwise remain 
tolerant to those MHC molecules. These results gave birth to the idea of MHC-
restriction.  
 Soon thereafter, the viral epitopes that stimulated T cells were identified to be 
short virus-derived peptides inserted into MHC molecules, validating the altered-self 
hypothesis [22, 23]. Additionally, the first structure of the MHC molecule was published 
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in the late 1980s by Don Wiley’s and Jack Strominger’s groups [24]. The structure 
clearly demonstrated that MHC molecules possessed a peptide binding groove that 
could be loaded by various peptides. Interestingly, the authors noted that there was 
additional electron density in the peptide binding groove that could not be accounted 
for by the MHC molecule. Since the authors did not load the MHC molecule with any 
peptide prior to crystallization, they rightly predicted that the electron density 
represented a mixture of peptides, potentially derived from intracellular protein 
fragments. 
 Despite significant progress in understanding the MHC-restricted responses by T 
cells, the nature of the TCR remained elusive for years. One consequence of this was 
that it was unclear whether B cells and T cells used the same set of genes to produce 
their antigen receptors [25, 26]. Furthermore, if they used the same genes, why did B 
cells not display the same MHC-restriction that T cells did? An answer came when the 
TCR proteins were first isolated and the determined polypeptide sequences were not 
shared by antibody sequences [27, 28]. Two separate groups then identified the TCR 
genes present in mice and humans and found them to be distinct from the genes coding 
for antibodies [29-31]. Such a result raised the possibility that unlike BCR genes, TCR 
genes had been evolutionarily selected to interact with MHC ligands.     
1.4 MHC genomic organization 
 Classical MHC genes are all clustered together on chromosome 17 in mice 
(chromosome 6 in humans). Mice possess two MHC-II genes and three MHC-I genes. 
The two murine MHC-II molecules are named I-A and I-E. Both of the molecules are 
heterodimers composed of α and β chains (I-Aα/I-Aβ and I-Eα/I-Eβ) [32]. Thus, the 
peptide binding groove is created together by both chains. The genes coding for the α 
and β chains corresponding to a given MHC-II molecule are adjacent to each other. 
Interestingly, not all strains of mice can functionally express I-Eα and strain-dependent 
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reasons have been identified for this observation [33]. Consequently, several strains of 
mice (including C57BL/6) can exclusively express only the I-A heterodimer as a 
functional MHC-II molecule. Centromeric to the genes coding for the MHC-II chains are 
the α and β genes coding for H2-DM. These genes code for a non-classical MHC-II 
molecule that mediates peptide exchange in the endo-lysosomal compartments [34]. 
The promoters for MHC-II genes possess binding sites for class II transactivator 
(CIITA), a transcription factor crucial for proper MHC-II gene expression [35]. While 
only certain cell types (professional antigen presenting cells) express surface MHC-II at 
steady-state, MHC-II gene expression can be induced in other cell types by 
environmental stimuli, such as IFN-γ [36, 37]. 
 Classical MHC-I genes instead each code for a single heavy chain such that the 
entire peptide binding groove is coded for by a single MHC-I gene [32]. In mice, the 
three MHC-I molecules are named H-2D, H-2K, and H-2L. However, expression of the 
H-2L gene is either reduced or absent in some mouse strains [38]. The MHC-I region 
also contains numerous other genes (some of which are pseudogenes) coding for non-
classical (MHC-Ib) MHC proteins. Interestingly, the MHC-I (and MHC-Ib) code for 
chains that require association with a small, globular protein called β2-microglobulin 
(β2m) for proper surface expression. The β2m gene is located on chromosome 2 in 
mice (chromosome 15 in humans). Of note, a given MHC-I or MHC-II allele in mice is 
denoted by a superscript letter (I-Ab or Kd, for example) corresponding to the 
designated MHC haplotype to which the allele belongs.  
1.5 Antigen presentation by MHC molecules 
 MHC-I and MHC-II molecules sample distinct antigenic spaces. In the case for 
MHC-I molecules, the goal is to sample all intracellular protein products. Intracellular 
proteins are primarily degraded by proteasomes into short peptides [39]. These 
peptides are translocated into the endoplasmic reticulum by the ER-resident protein 
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transporter associated with antigen presentation (TAP) [40]. In this manner, as the 
nascent MHC-I polypeptides are being assembled and folded in the ER with β2m, they 
become associated with the peptide fragments present in the ER. The peptide binding 
cleft in MHC-I molecules can normally accommodate peptides that are 8-10 amino acids 
long (Figure 1.1A). Subsequently, the entire peptide/MHC-I/β2m complex is 
transported to the surface for antigen presentation [39]. Since the bound peptides are 
fragmented products of all intracellular proteins, the MHC-I antigen presentation 
pathway samples all the intracellular protein content at any given timepoint. Thus, 
during a viral infection, viral proteins are processed and presented by MHC-I molecules 
to potentially activate T cells with TCRs specific for such complexes. 
 MHC-II molecules, instead, sample extracellular space. For this purpose, although 
they are assembled and folded in the ER as well, peptide loading for MHC-II molecules 
does not occur in the ER. Instead, they associate with a molecule called invariant chain 
(Ii) that helps transport the complex to late endosomal compartments [41]. Here, as 
previously mentioned, H2-DM facilitates peptide loading with peptides originating from 
proteins degraded in the endocytic pathway [39]. These peptides can be of variable 
length and peptide lengths ranging from 10 to 20 amino acids have been reported to be 
loaded onto MHC-II molecules (Figure 1.1B). The peptide loaded MHC-II molecule is 
then transported to the cell surface for antigen presentation. 
 Importantly, the bound peptides for both MHC-I and MHC-II proteins create 
important contacts with the residues present in the peptide binding groove. Certain 
peptide residues create more contacts with the residues in the groove and are referred 
to as anchor residues [42, 43]. Consequently, although the amino acid sequence of the 
loaded peptides is still diverse, the nature of the anchor residues is more restricted to 
ensure that peptides are more stably inserted in the groove. Interestingly, the 




Figure 1.1 Structure of murine MHC molecules. A Representation of the mouse 
Kb MHC-I molecule associated with the dEV8 (EQYKFYSV) peptide (pdb: 2CKB). The 
Kb heavy chain is colored in red, β2m is colored in gray and the peptide is colored in 
green. B Representation of the mouse I-Ab MHC-II molecule associated with the 3K 
(FEAQKAKANKAVDG) peptide (pdb: 3C5Z). The I-Abα chain is colored in red, the I-
Abβ chain is colored in orange, and the peptide is colored in green. The left panels are 
side views of the complexes. The middle panels are top views from the perspective of 
the TCRs. The right panels are top views with the CDR loops for the cognate TCRs (A 
2C TCR and B B3K506 TCR) overlayed. The loops are colored as follows: CDR1α in 
light blue, CDR2α in magenta, CDR3α in yellow, CDR1β in blue, CDR2β in purple and 
CDR3β in light brown. Cartoon representations were created in PyMOL.  
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Thus, on a population level, the restrictions imposed on anchor residues are not as 
strict. 
 Lastly, the two classes of MHC molecules present their peptides to distinct αβ T 
cells. MHC-I molecules present their peptides to TCRs on T cells co-expressing CD8 
while MHC-II molecules present peptides to TCRs on T cells that also express CD4 
[44]. The two types of T cells display a functional division of labor, which can be broadly 
categorized into cytotoxic (CD8+ T cells) and helper (CD4+ T cells) functions. CD8+ T 
cells can directly lyse cells bearing their cognate antigens, which can be useful in viral 
and intracellular bacterial infections. CD4+ T cells, on the other hand, secrete specific 
chemokines and cytokines upon activation and recruit/activate other cells. Overall, the 
nature of the immunogenic insult determines how antigens are presented to T cells and 
subsequently, influences the course of the immune response.  
1.6 TCR genomic organization 
 The TCR loci are spread out over three separate regions in mice. The TCRβ and 
TCRγ loci are unlinked and present on chromosome 6 and chromosome 13 in mice, 
respectively (chromosome 7 in humans). Interestingly, the TCRδ locus is contained 
within the TCRα locus on chromosome 14 in mice and humans [45]. Cells expressing 
functional TCRγ and TCRδ rearrangements give rise to a special population of T cells 
called γδ T cells and are reviewed elsewhere [46]. Both the TCRα and TCRβ loci are 
organized similarly. At the 5’ end of the loci are numerous variable genes (referred to as 
TRAV and TRBV for TCRα and TCRβ genes, respectively). In the TCRα locus of the 
C57BL/6 mouse, there are 138 total TRAV genes of which 21 have been classified as 
pseudogenes [45]. The TCRβ locus only possesses 31 TRBV genes of which 23 are 
functional [47]. Towards the 3’ end of the loci are the joining (TRAJ and TRBJ for the 
two loci) genes, with 60 TRAJ genes (43 are functional) and 14 TRBJ genes (12 of which 
are functional). Further 3’ of the J-genes, are constant genes (TRAC and TRBC), with 
9 
 
the TCRα locus possessing a single TRAC gene while the TCRβ locus possesses two 
TRBC genes. Of note, the TCRβ locus also possesses 2 diversity (TRBD) genes that the 
TCRα locus lacks. Interestingly, the TRBD, TRBJ and TRBC genes are not continuous in 
the TCRβ locus as their counterparts are in the TCRα locus. These genes are split into 
two cassettes – with TRBD1, seven TRBJ1 genes, and TRBC1 composing one cassette 
while TRBD2, seven TRBJ2 genes, and TRBC2 compose the other [47]. Notably, the 
TRBV31 gene is also oddly positioned not adjacent to the other TRBV genes but instead 
at the end of TCRβ locus downstream of TRBC2. Lastly, each of the genes is in fact a 
gene fragment and cannot code for a complete or functional protein by itself. 
 Each of the aforementioned genes (except for the constant genes) are flanked by 
specific sequences called recombination signal sequences (RSSs) [48]. Each RSS comes in 
one of two flavors – a 12RSS or a 23RSS. The RSS itself is organized in a specific manner 
with a heptamer sequence, a spacer sequence of either 12 or 23 nucleotides (which 
determines the type of RSS), and a nonamer sequence. The heptamer and nonamer 
sequences are well conserved while the spacer sequences do not display sequence 
conservation but rather strict length conservation [47, 48]. Additionally, the RSS 
displays a polarity, with the nonamer distal to the antigen receptor gene and the 
heptamer directly adjacent to the gene. All V-genes possess a 23RSS on their 3’ ends 
and all J-genes possess a 12RSS on their 5’ ends. The TRBD genes are flanked on both 
sides with RSSs – a 12RSS on their 5’ ends and a 23RSS on their 3’ ends. 
1.7 TCR gene rearrangement and antigen receptor diversity 
 During T cell development, the TCR loci undergo a series of coordinated and 
timed epigenetic and genetic modifications. Chief among these is the process of somatic 
DNA rearrangement termed V(D)J recombination. During this recombination, genes 
that are initially distantly located from each other are looped into close proximity by 
protein complexes [4, 47]. The primary enzyme mediating this DNA looping is the 
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recombination activating gene (RAG) enzyme that is composed of RAG1 and RAG2 
proteins. RAG specifically binds to the RSSs to mediate its functions. Initially, RAG binds 
to a 12RSS or 23RSS. Next, through a ‘capture’ mechanism, the bound RAG mediates 
juxtaposition with another antigen receptor gene lacking any RAG proteins [49]. 
Importantly, recombination only occurs between 12RSS and 23RSS genes, a 
phenomenon referred to as the 12/23 rule of recombination [50]. Next, RAG generates 
double stranded DNA breaks in this paired complex. Eventually, due to the DNA 
breaks, proteins in the cellular classical non-homologous end joining (NHEJ) pathway 
are activated, which then resolve the double stranded breaks [51]. The NHEJ pathway 
in developing T cells is unique because it also includes a role for the template-
independent DNA polymerase terminal deoxynucleotidyl transferase (TdT) [52, 53]. 
This enzyme stochastically adds nucleotides to the junctions between the two 
juxtaposed genes and consequently, creates a DNA sequence that was not present in 
the germline. Overall, the entire process creates a novel coding segment and results in 
the removal of any intervening DNA between the two rearranged genes. 
 T cells developing in the thymus express various markers on their cell surfaces as 
they mature [54]. Initially, the cells are doubly negative for cell surface expression of the 
coreceptor proteins CD4 and CD8 and are called DN cells. DN cells follow a pathway 
defined by their cell surface expression of CD25 and CD44 and are categorized into the 
DN1-4 stages. Upon maturing to the DN4 stage, the cells rapidly increase their cell 
surface expression of CD4 and CD8 and are called double positive (DP) thymocytes. 
Rearrangements at the TCR loci occur at these various stages of development.  
 DN2 thymocytes initiate rearrangements between TRBD and TRBJ genes to first 
create a DJ join (Figure 1.2A) [55]. Next, after the cell progresses to the DN3 stage, a 




Figure 1.2 Rearrangement in the TCR loci. A During thymocyte development, 
the TCRβ locus is first rearranged. This involves first rearranging a TRBD gene to one of 
the TRBJ genes in DN2 thymocytes. Subsequently, a TRBV gene rearranges with the DJ 
rearrangement in DN3 thymocytes. B Upon productive TCRβ locus rearrangement, the 
cells mature into DP thymocytes. At this stage, TRAV genes can recombine with TRAJ 
genes to create a functional TCRα chain. The numbers in parentheses correspond to 










segment. At this point, the coding segment is assessed for its ability to code for a 
productive protein. This is an especially important check by the cell since the 
recombination machinery does not inherently select for any particular reading frame, 
but only one of the three reading frames is capable of producing a functional protein. 
Yet, the VDJ join by itself still remains an incomplete coding sequence. Once the 
rearrangement is transcribed to RNA, it is spliced to one of the two TRBC genes that 
can now be fully translated, and the productivity of the resulting polypeptide can be 
finally assessed. 
 A productive protein serves as a survival signal and promotes transition of the 
DN3 thymocyte to the DN4 stage and eventually into the DP population [56, 57]. An 
unproductive rearrangement is quickly degraded and recombination by RAG proteins is 
initiated again in the TCRβ locus in the homologous chromosome [58]. While a 
productive rearrangement in this instance would still promote progression of the DN3 
cell to the DP stage, a second unproductive rearrangement instead leads to apoptosis 
by the DN3 thymocyte due to an absence of survival signals. A similar process occurs at 
the DP stage for rearrangements in the TCRα locus (Figure 1.2B). However, one 
major distinction is that since the TCRα locus lacks any D-genes, the TRAV and the 
TRAJ genes directly recombine with one another. One other consequence of no D-
genes is that if an unproductive rearrangement is generated initially, RAG can continue 
to recombine TRAV and TRAJ genes on the same chromosome by using genes distal to 
the ones initially involved in the rearrangement, thereby increasing the probability of 
generating a functional rearrangement [45]. Since the DP cell already possesses a 
productive TCRβ chain, upon generating a productive TCRα chain, a complete αβ TCR 
can first be expressed at the DP thymocyte stage. In this manner, although a given DP 
thymocyte expresses multiple copies of an αβ TCR on its surface, each copy expressed 
by the cell is identical and the cell is monospecific. Overall, because (1) there are 
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numerous antigen receptor genes, (2) RAG-mediated recombination can largely 
juxtapose all the genes within a locus, (3) random nucleotides are added to the 
recombined junctions by TdT, and (4) the TCR is a heterodimer, the number of unique 
TCR heterodimers has been estimated to exceed 1015 receptors [5]. Thus, a 
theoretically diverse TCR repertoire can be generated with relatively few genes due to 
the nature of V(D)J recombination.  
1.8 Thymic selection 
 Expression of a complete αβ TCR on DP thymocytes allows these cells to be 
interrogated for selection. This process accomplishes two important tasks [59, 60]. 
First, it selects for cells expressing TCRs that can interact with self MHC molecules 
(positive selection) expressed by thymic antigen presenting cells (APCs). In the 
periphery, αβ T cells can only mount immune responses when they encounter self MHC 
molecules presenting foreign peptides. Thus, positive selection in the thymus ensures 
that only the cells with TCRs capable of interacting with self MHC are maintained. 
Second, cells that interact too strongly with self MHC molecules are culled from the 
population (negative selection). In doing so, the thymus removes any cells bearing 
autoreactive TCRs to prevent any potential autoimmunity in the periphery. The entire 
process of thymic selection is also referred to as education (since TCRs need to be 
educated on self MHC) and central tolerance (developing thymocytes are tolerized to 
self by removing autoreactive cells).  
 The coreceptor molecules are not innocuously expressed at the DP stage. CD4 
and CD8 possess extracellular specificities for MHC-II and MHC-I molecules, 
respectively. Intracellularly, they associate with the kinase Lck that helps initiate the 
TCR signaling cascade [61-63]. Thus, by intracellularly sequestering Lck and 
extracellularly interacting with MHC molecules, the coreceptors are thought to 
preferentially bias the selection of DP thymocytes expressing MHC-restricted TCRs. If a 
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DP thymocyte receives a TCR-mediated signal of sufficient strength, then the 
thymocyte further matures into a CD4+ or CD8+ thymocyte (depending on the 
selecting MHC molecule) and this cell is exported out of the thymus where it enters 
the peripheral αβ T cell population. Approximately 90% of the DP thymocytes, 
however, die due to not receiving a TCR-mediated signal, a phenomenon dubbed 
‘death-by-neglect’ [64]. Overall, although recombination generates a diverse pool of 
TCRs, a vast majority of them are deemed worthless by selection, making thymic 
development an inefficient and energetically expensive process.  
1.9 Why are TCRs MHC-restricted? 
 One of the outstanding questions in T cell biology is the reason behind the 
MHC-restriction of αβ TCRs. If TCRs with myriad specificities can be generated by 
V(D)J recombination, why are all of them specific for MHC molecules? Developing B 
cells also possess the same recombination machinery to create a large repertoire of 
BCRs. Yet, those antigen receptors are not restricted to interacting with MHC 
molecules and instead display various specificities including for other peptidic and non-
peptidic antigens [65, 66]. This raises the question – are TCRs predisposed to 
interacting with MHC molecules even prior to selection or does thymic selection 
instead impart MHC-restriction by exclusively maturing cells bearing MHC-restricted 
TCRs? In this thesis, I will provide evidence supporting the hypothesis that TCRs have 
co-evolved to interact with MHC molecules even in the absence of any selection. 
   To properly address this question, we created an in vitro system in which we 
could test the specificities of libraries of TCRs. Chapter II focuses on the generation 
of a TCR- T cell hybridoma expressing an inducible GFP reporter under the control of 
the NFAT transcription factor. Various TCRs with defined specificities could be 
expressed in these cells and stimulated, with induction of GFP serving as a readout of 
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the extent of stimulation. Overall, a sensitive reporter hybridoma was produced into 
which we could express TCRs in a modular way. 
 Next, in Chapter III, unselected TCR libraries were ectopically expressed in 
the reporter hybridomas and the TCR+ hybridomas were interrogated for their 
specificities. Relatively weak reactivities were observed when the hybridomas were 
cultured with various APCs expressing unique MHC alleles. However, when the 
hybridomas were forced to overexpress coreceptors and then cultured with APCs, the 
reactivities were dramatically improved. Thus, an underlying bias does exist with TCRs 
to react with MHC molecules and these are enhanced by coreceptors. 
 Lastly, in Chapter IV, future experiments are discussed. Various functional, 
structural, repertoire and evolutionary analyses are proposed. Conducting such 
experiments may provide further insight into the nature of how TCRs are MHC-
restricted.  























T CELL HYBRIDOMAS EXPRESSING A NFAT-GFP REPORTER 
Our goal was to determine whether a repertoire of unselected TCRs intrinsically 
displayed a bias to interact with MHC molecules. To ensure that we could control the 
various parameters we were interested in testing, we elected to use an in vitro system. 
In such a setting, we could ectopically express different TCRs in a cell line and then 
assess how the cells responded to various stimuli. One aspect that would be key to this 
in vitro system would be a reliable readout of stimulation. Additionally, to specifically 
identify the responding vs. non-responding cells, the system would need to resolve such 
differences at the single cell level. 
Two main types of cells are commonly used to express TCRs and test their 
reactivities. Mouse TCRs are frequently re-expressed in TCR- T cell hybridomas via 
stable transfection or retroviral transduction [67, 68]. Although these hybridomas 
originally expressed a functional TCR, they were selected for genetic loss of both 
chains. Despite lacking a TCR, they continue to express the various signaling 
components required to propagate a TCR-mediated signal. Thus, these hybridomas 
serve as empty vessels into which TCRs of interest can be expressed and tested. When 
studying the reactivities of human TCRs, Jurkat cells (and their derivatives) are a popular 
immortalized cell line into which human TCRs can be expressed [69, 70]. These are 
leukemic cells initially isolated from a patient with T cell leukemia [71]. Subsequently, 
they were selected in various manners by Arthur Weiss to generate a TCR-deficient cell 
line, similar to the manner in which the TCR- T cell hybridomas were generated. 
Signaling downstream of TCR engagement has been studied extensively. Briefly, 
after TCR engagement, the Src family kinase Lck first phosphorylates the 
immunoreceptor tyrosine-based activation motifs (ITAMs) present within the CD3 
subunits. This helps recruit and eventually activate the kinase Zap70, which propagates 
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the TCR signaling cascade via various proteins and adapters [72]. The cascade 
culminates in the activation of two transcription factors – nuclear factor of activated T 
cells (NFAT) and nuclear factor (NF)-κB [73-76]. As a consequence of signaling, calcium 
is released from the endoplasmic reticulum (ER) into the cytosol, which in turn leads to 
dephosphorylation of cytosolic NFAT and its translocation into the nucleus. 
Concurrently, the inhibitor of κB (IκBα) is marked for proteasomal degradation, ending 
the cytosolic sequestration of NF-κB and promoting its translocation into the nucleus as 
well. Once in the nucleus, the two transcription factors coordinate with each other and 
other factors and introduce transcriptional changes by binding to their target sites and 
initiating transcription of various genes. Two such target genes are the Il2 (coding for 
the secreted cytokine interleukin-2) and the Cd69 (coding for the membrane-bound 
CD69 protein) genes [77-80].  
Upon expressing TCRs in either cell type and stimulating the cells, two common 
readouts of stimulation are measuring amount of secreted IL-2 in the supernatant 
and/or CD69 upregulation on the cells [81, 82]. Higher levels of measured IL-2/CD69 
indicate a stronger stimulation. However, both these measurements should be 
interpreted with a degree of caution. In the case of IL-2, since the supernatant from the 
stimulation culture is used to determine the concentration of IL-2, this metric evaluates 
the overall IL-2 secreted by the responding cells without identifying the specific 
stimulated cells. Thus, when a certain concentration of IL-2 is measured in the 
supernatant, it is unclear whether proportionally few cells were each stimulated 
strongly or proportionally many cells were each stimulated relatively weakly but 
similarly. By contrast, measuring levels of CD69 on cells upon stimulation affords the 
ability to specifically identify any stimulated cell instead of relying on a bulk 
measurement. However, although CD69 is frequently referred to as a marker of 
activation [83], its upregulation on cells may not always be due to direct TCR 
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engagement. Cytokine-mediated signaling has also been shown to cause upregulation of 
CD69 [84]. Cells could, therefore, express higher levels of CD69 by responding to 
cytokines in the supernatant without necessarily ever having been stimulated by their 
TCRs. Overall, a different metric needs to be utilized that can serve as a reliable 
indicator of TCR-mediated stimulation while simultaneously identifying individually 
stimulated cells.  
2.1 Generating a reporter cell line to measure TCR stimulation 
To circumvent the aforementioned issues, we took advantage of a transcription 
factor-driven reporter system that we could express in cells. In this system, enhanced 
green fluorescent protein (GFP) was under the control of three tandem NFAT-binding 
sites [85]. Thus, in cells bearing this construct, GFP was not constitutively expressed 
but rather only expressed upon stimulation causing NFAT translocation into the 
nucleus and subsequent NFAT binding to these target sites. In this manner, we could 
individually identify cells that were specifically stimulated through their TCRs. 
 Since our goal was to test murine TCRs, we first introduced the reporter 
construct into the 58 α-β- T cell hybridoma cell line (Figure 2.1A) [68]. After sorting 
on human CD4 (hCD4, a surrogate marker of transduction lacking its intracellular tail) 
to ensure that all cells expressed the reporter, we confirmed that the cells upregulated 
GFP in response to phorbol 12-myristate 13-acetate (PMA) and the ionophore 
ionomycin (Figure 2.1B). These compounds are cell membrane-permeable and can 
activate NFAT by bypassing the proximal TCR signaling cascade [86]. Next, we 
introduced a TCR in the cells to determine whether these cells were indeed capable of 
upregulating GFP when stimulated via the TCR. We expressed the B3K506 TCR, which 
is an αβ TCR that recognizes a variant of the Eα52-68 peptide presented by the I-Ab 
MHC-II molecule [87]. After sorting for TCRβ+ cells, we stimulated the cells with plate-
















Figure 2.1 NFAT-GFP reporter construct. A The NFAT-GFP reporter retroviral 
plasmid map is depicted. Truncated human CD4 (this molecule lacks a cytoplasmic tail) 
is a surrogate marker to confirm viral integration upon infecting cells. GFP is placed in 
reverse orientation with respect to the 5’ long terminal repeat (LTR) so its expression 
is driven specifically by the upstream NFAT binding sites. The plasmid is a self-
inactivating vector (SIN) to ensure that no replication-competent virus is produced by 
the infected cells. B Left, T cell hybridomas possessing the NFAT-GFP reporter 
construct uniformly express hCD4 (shaded histogram corresponds to antibody staining 
of untransduced hybridomas). Right, Stimulating reporter-expressing hybridomas using 
PMA and ionomycin leads to GFP upregulation (shaded histogram corresponds to GFP 





























Figure 2.2 Stimulating TCR-expressing hybridomas using antibodies. A GFP 
induction was measured in reporter+ hybridomas expressing the B3K506 TCR upon 
stimulation by plate-coated antibodies targeting CD3 at the indicated concentrations. B 
CD28 levels in hybridomas upon CD28 overexpression (shaded histogram corresponds 
to CD28 expression in endogenous hybridomas). C Secreted IL-2 in the culture 
supernatant was measured by ELISA after stimulating CD28+ B3K506+ hybridomas using 
plate-coated antibodies targeting only CD3 or CD3 and CD28 at the indicated 
concentrations. D GFP induction was measured in CD28+ B3K506+ hybridomas upon 
stimulation by plate-coated antibodies targeting CD3 and CD28 at the indicated 




absence of any stimulation, the cells remained GFP- but they responded to the antibody 
stimulation in a dose-dependent manner by turning GFP+. Thus, the presence of GFP in 
the cells was a true indicator of TCR-mediated stimulation and the stimulated cells 
could be used to individually identify stimulated cells. 
2.2 Increasing the sensitivity of the responding hybridomas 
Although the reporter-bearing cells were responding to stimulation, it was clear 
that even at high doses of stimulation, not all cells were responding. To increase the 
proportion of responding cells, we first retrovirally introduced the costimulatory 
molecule CD28 as the hybridomas do not endogenously express this molecule (Figure 
2.2B). Since engaging CD28 has also been shown to activate NFAT [88], we predicted 
that we would observe a stronger response when we stimulated the cells using plate-
coated antibodies targeting both CD3 and CD28. Indeed, the proportion of responding 
cells approximately doubled when CD28 was engaged as well (Figure 2.2D). Measuring 
IL-2 secretion by enzyme-linked immunosorbent assay (ELISA) also provided a similar 
readout (Figure 2.2C). However, still only approximately 40% of the hybridomas were 
responding even in the strongest stimulation conditions.  
Due to possessing twice as many chromosomes as a normal murine cell, 
hybridomas have unstable genomes [89]. Therefore, although all cells possessed the 
reporter, not all of them may have possessed the appropriate molecules in the signaling 
pathway to properly upregulate GFP. To resolve this, we generated single cell clones 
from the bulk TCR- CD28+ cells by limiting dilution. In this manner, we obtained 12 
different clones, each of which expressed the reporter. Subsequently, we expressed the 
B3K506 TCR in each of the clones and screened each of them for their ability to 
respond to TCR-mediated stimulation by upregulating GFP.  
We stimulated each of the clones with plate-coated antibodies targeting CD3 





















Figure 2.3 Identifying a clone sensitive to stimulation. Single cell clones were 
isolated by limiting dilution and each transduced with the B3K506 TCR. Subsequently, 
GFP induction in each clone was measured upon stimulation using plate-coated 
antibodies targeting CD3 and CD28 each at 10 μg mL-1. The clone boxed in red (Clone 
11) was identified as the clone most sensitive to stimulation. Experiment was conducted 












proportion of stimulated cells varied from clone to clone, where in some cases only 
~4% of the cells upregulated GFP, confirming that not all the cells were genomically 
equivalent. However, one of the clones (Clone 11) responded strongly to the 
stimulation with ~80% turning GFP+. We proceeded with the TCR- version of this 
clone.  
Efficient expression of αβ TCRs on the membranes of T cells requires proper 
association with the CD3 subunits [90-92]. Despite the fact that the TCRα and TCRβ 
chains could be overexpressed in these cells, their surface expression was still limited by 
the quantity of the CD3 subunits present in the cells. Reduced TCR density on T cells 
decreases their functional avidities and leads to poorer responses by the cells [93, 94]. 
To overcome this limitation, we retrovirally overexpressed the different CD3 subunits 
in the hybridomas [95]. By additionally expressing the B3K506 TCR, we observed >20-
fold increase in TCRβ surface expression, confirming that the amount of endogenous 
CD3 subunit expression was regulating TCR surface levels. Furthermore, we verified 
that the cells displayed greater sensitivity to stimulation by measuring GFP induction in 
the cells upon plate-bound antibody stimulation (Figure 2.5A). Overall, we isolated a 
sensitive hybridoma clone into which we overexpressed CD28 and the CD3 subunits. 
2.3 Hybridomas only express the introduced TCR 
 The 58 hybridoma was isolated in 1989 and has been widely distributed since. 
When this hybridoma was initially characterized, the authors identified a TCRα 
rearrangement in the genome [68]. However, this rearrangement possessed a 
termination codon early in the open reading frame and thus, the authors characterized 
the Vα (TRAV) gene in this rearrangement as a pseudogene. Based on the published 
sequence, the V-gene can be identified as TRAV20, which is indeed a pseudogene 
(Figure 2.4A). Despite this, since hybridomas have plastic genomes with insertions and 

















Figure 2.4 Endogenous TCRα chain is not expressed in hybridomas. A 
Murine TRAV20 is a pseudogene due to multiple termination codons early in its coding 
sequence. B Hybridomas were transduced with no TCR, the B3K506α chain only, the 
B3K506β chain only, or the complete B3K506 TCR. Plots assessing surface TCR levels 
for each of the hybridoma transductants are depicted. C Histograms are overlayed to 
depict the TCR levels in each of the hybridoma transductants. The fluorescence 
intensities (gMFI) corresponding to the TCR levels for each cell population are noted as 


























Figure 2.5 Characteristics of stimulated hybridomas. A Top, GFP induction of 
B3K506+ hybridomas overexpressing the various CD3 subunits stimulated by plate-
coated antibodies targeting CD3 and CD28 at the indicated concentrations. Bottom, 
The proportion of GFP+ cells, the gMFI of the GFP+ cells, and the proportion of TCRβ+ 
cells as a function of antibody dose are plotted. B Top, GFP induction of B3K506+ 
hybridomas stimulated by I-Ab-expressing CHB-2.4.4 cells pulsed with the 3K peptide at 
the indicated concentrations. Bottom, The proportion of GFP+ cells, the gMFI of the 
GFP+ cells, and the proportion of TCRβ+ cells as a function of peptide dose are plotted. 
Data are representative of two independent experiments with two replicates per 








not repair the pseudogene so it could now be expressed. We independently expressed 
just the B3K506 TCRα chain, just the B3K506 TCRβ chain, or the complete B3K506 αβ  
TCR in the hybridomas. We then measured the TCR levels in each of the infected 
hybridomas as well as the TCR- hybridoma to observe whether an endogenous TCRα 
rearrangement was being expressed and pairing with the introduced TCRβ chain 
(Figure 2.4B). If so, this would obfuscate our results because the specificity of any 
introduced TCR would be diluted due to pairing of the endogenous TCRα chain with 
the TCRβ chain, thereby creating a novel specificity. 
 When we measured the surface TCR levels in each of the hybridomas, the TCR- 
hybridomas were predictably negative for TCR expression (gMFI of 91) (Figure 2.4C). 
Importantly, surface TCR could be observed in neither the TCRβ only nor the TCRα 
only hybridomas (gMFI of 145 and 90, respectively). Only hybridomas that received the 
complete B3K506 αβ TCR expressed surface TCRs that could be measured (gMFI of 
24220). We, therefore, concluded that the endogenous TRAV20 rearrangement 
continues to be nonproductive in our hybridomas and does not pair with any 
introduced TCRβ chains.    
2.4 Hybridomas respond to antigen in a dose-dependent manner 
Thus far, we had only tested the responses by the hybridomas when stimulated 
with plate-coated antibodies. The hybridomas responded in a dose-dependent manner 
in this setting (Figure 2.5A). Furthermore, three different metrics could be used to 
determine the extent to which the hybridomas were stimulated. First, the proportion of 
GFP+ hybridomas increased with the dose of stimulation. Second, the gMFI of the GFP+ 
cells also increased with dose, suggesting that the responding cells experienced a 
stronger signal as a function of dose. Third, fewer and fewer hybridomas retained 
surface expression of TCR as the dose of stimulation increased. T cells downregulate 
TCR in response to strong stimulation and the hybridomas acted similarly [96].  
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Next, since the B3K506 TCR has a well-defined specificity, we tested the ability 
of the cells to respond in an antigen presentation assay. As mentioned previously, the 
B3K506 TCR is MHC-II-restricted and recognizes a modified version of the Eα52-68 
peptide presented by I-Ab. In this peptide variant, three of the solvent-exposed residues 
with which the TCR can interact were each mutated to lysine residues, thereby 
spawning the name 3K to identify this peptide [97, 98]. We co-cultured the hybridomas 
with the I-Ab expressing CHB-2.4.4 cells [99] and pulsed the 3K peptide in the culture 
at different concentrations. As we had observed in the antibody stimulations, the 
hybridomas responded to the pMHC complex in a dose-dependent manner, with an 
increased proportion of GFP+ cells and an increased gMFI of the GFP+ cells as a function 
of peptide dose (Figure 2.5B). Interestingly, surface TCR expression remained 
unchanged at all tested peptide concentrations, suggesting that the peptide-based 
stimulations were not as potent as the antibody-based stimulations.  
2.5 Characteristics of hybridoma responses 
Although the cells were responding to antigenic stimulation in a predictable 
manner, it was still unclear whether all the responding cells were directly engaging 
antigen or if they were instead upregulating GFP independent of antigen. Such a 
scenario would be reminiscent of how CD69 expression is not always dependent on 
stimulation through the TCR [84]. To gain more insight into how the hybridomas were 
responding, we independently expressed an invariant natural killer T (iNKT) TCR in the 
cells. iNKT cells are a unique population of T cells bearing TCRs that recognize lipids in 
the context of the non-polymorphic MHC-I-like molecule CD1d [100]. Compared to 
the B3K506 TCR, the iNKT TCR is restricted to a different MHC molecule and 
recognizes a different class of antigen altogether. Thus, there would be no antigenic 
overlap between the two TCRs. 
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We initially overexpressed CD1d in the CHB-2.4.4 APCs [101]. The same cell 
line was now capable of presenting the 3K peptide on I-Ab to B3K506 bearing 
hybridomas as well as lipids on CD1d to the iNKT bearing hybridomas. To first confirm 
that there was no crosstalk between the two TCRs, we added the 3K peptide and the 
antigenic lipid α-galactosylceramide (αGC) to co-cultures between the two sets of 
hybridomas and the APCs. Each of the hybridomas was cultured and stimulated by both 
antigens separately. As expected, the B3K506 hybridomas were unresponsive in the 
presence of αGC but responded strongly in the presence of the 3K peptide (Figure 
2.6A). The iNKT hybridomas responded in a reciprocal manner where they were only 
stimulated in the presence of αGC. Thus, the hybridomas only responded when their 
cognate antigens were included in the culture.  
Next, we sought to identify whether specifically stimulating some hybridomas 
was sufficient to stimulate other hybridomas non-specifically. Having established that the 
two sets of hybridomas are antigen-specific, we tested how the hybridomas would 
respond in two separate conditions – one in which all the hybridomas bear the iNKT 
TCR and one in which half the hybridomas exclusively bear the iNKT TCR while the 
other half exclusively expresses the B3K506 TCR. In the second condition, at best, only 
half of the hybridomas would be capable of responding when cultured with APCs pulsed 
with αGC. Indeed, that is precisely what we observed (Figure 2.6B). Thus, we can 
conclude that GFP induction in the hybridomas is both antigen-specific and antigen-
dependent as the B3K506 hybridomas did not non-specifically upregulate GFP in the 
presence of GFP+ iNKT hybridomas. 
2.6 Ratio of the stimulator to responder cells influences stimulation 
 In all the previous experiments involving antigen presentation, we had maintained 




















Figure 2.6 Hybridoma responses require cognate antigens. A Hybridomas 
expressing an iNKT TCR and hybridomas expressing the B3K506 TCR were 
independently cultured with CD1d+ CHB-2.4.4 APCs in conjunction with either the 3K 
peptide (50 ng mL-1) or the αGC lipid (25 ng mL-1). The proportion of GFP+ hybridomas 
are depicted in each stimulation condition. B CD1d+ CHB-2.4.4 cells were cultured 
either exclusively with iNKT hybridomas or with B3K506 and iNKT hybridomas 
together at a 1:1 ratio and proportion of GFP+ cells was assessed for both conditions at 
various concentrations of added αGC lipid. Data are representative of two independent 







decreasing the ratio of hybridomas to APCs would increase the proportion of 
responding cells since each hybridoma would have more access to APCs presenting  
antigen. Eventually, though, this increase in responding cells would plateau due to the 
physical restraints of the cells/wells preventing more APCs from surrounding any given 
hybridoma. 
 We tested the proportion of responding hybridomas at different ratios of 
hybridomas to APCs. One of five different numbers of hybridomas was added to each 
well and cultured with one of six different numbers of APCs for a total of 30 
combinations tested. In these experiments, we used the iNKT TCR expressing 
hybridomas and measured their responses to a fixed concentration of αGC. As 
predicted, increasing the number of APCs in the stimulation increases the proportion of 
GFP+ hybridomas (Figure 2.7A). Inversely, decreasing the number of APCs in the 
stimulation decreases the proportion of hybridomas that induce GFP. Importantly, there 
was marginally increased proportion of GFP+ cells when a ratio of 1 hybridoma:10 APCs 
was exceeded. A similar finding was observed even when TCRβ downregulation as a 
consequence of stimulation was assessed (Figure 2.7B). Thus, the ratio (up to a certain 
threshold) between the two types of cells in culture is crucial in determining the 
fraction of hybridomas that upregulate GFP. In all future experiments, we used a ratio of 
1:10 of hybridomas to APCs to ensure we would obtain maximal responses.  
2.7 Bcl2 overexpression dampens the signaling in the hybridomas 
 Much like how primary T cells undergo activation-induced cell death (AICD) 
[102], hybridomas also undergo apoptosis when they receive strong TCR-mediated 
signals [103]. NFAT translocation into the nucleus upon TCR signaling leads to changes 
in the transcriptional landscape and increases in expression of many genes. One of the 
genes regulated by NFAT is Fasl [104-106]. The FasL protein coded for by this gene 








Figure 2.7 Ratio of hybridomas to APCs influences extent of stimulation. 
iNKT hybridomas were cultured with CD1d+ APCs at various ratios but a fixed 
concentration of αGC (25 ng mL-1) and the proportion of GFP+ cells (A) and TCRβ+ 
cells (B) was plotted for each of the tested conditions. Experiment was conducted once 















cells/hybridomas [107]. Stronger TCR signals have been linked to higher FasL expression 
and greater susceptibility to programmed death [108]. 
 To accurately determine the proportion of stimulated cells, our system relies on 
identifying the GFP+ cells present in the culture. However, if the cells undergo apoptosis 
upon stimulation, we would not be accurately measuring the proportion of stimulated 
cells. Instead, we would only be measuring the live GFP+ cells upon stimulation without 
accounting for any cells which underwent AICD and thereby, potentially 
underestimating the proportion of stimulated cells. To circumvent this, we 
overexpressed the anti-apoptotic membrane protein Bcl2. This protein is localized in 
the outer membrane of the mitochondria and exerts its anti-apoptotic functions 
primarily by maintaining mitochondrial integrity [109]. Bcl2 overexpression in 
hybridomas has also previously been shown to increase cell survival post-stimulation 
[110]. 
 We initially overexpressed Bcl2 in the hybridomas expressing the B3K506 TCR 
(Figure 2.8A). To confirm that the stimulation we had previously observed was not 
altered in the presence of Bcl2, we stimulated B3K506 hybridomas with or without 
overexpressed Bcl2 using plate-coated antibodies. Surprisingly, overexpression of Bcl2 
significantly reduced the response potential of the hybridomas to stimulation. The 
proportion of GFP+ cells overexpressing Bcl2 was ~8-fold reduced (Figure 2.8B). The 
gMFI of the responding cells and the proportion of TCRβ- cells were also reduced. 
Similar results were observed when we stimulated both sets of cells in an antigen 
presentation assay (Figure 2.8C). Thus, overexpressing Bcl2 dampened the signals 
within the hybridomas and inhibited the cell responses. 
 Importantly, when viability was assessed by forward-scatter (FSC) by side-scatter 
(SSC) biaxial plot measurements, the proportion of Bcl2- and Bcl2+ cells landing in the 
‘Live’ gate in the antibody-stimulated condition was not appreciably different (~88% vs  
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Figure 2.8 Overexpressing Bcl2 dampens TCR-mediated signals in 
hybridomas. A Levels of Bcl2 in hybridomas either overexpressing Bcl2 (called Bcl2+ 
cells) or not (called Bcl2- cells). B Bcl2+ and Bcl2- cells were separately stimulated using 
plate-coated antibodies targeting CD3 and CD28 at the indicated concentrations. The 
proportion of GFP+ cells, the gMFI of the GFP+ cells, and the proportion of TCRβ+ cells 
are plotted for both cell populations. C Bcl2+ and Bcl2- cells were separately stimulated 
in antigen presentation assays with CHB-2.4.4 APCs and 3K peptide added at the 
indicated concentrations. The proportion of GFP+ cells, the gMFI of the GFP+ cells, and 
the proportion of TCRβ+ cells are plotted for both cell populations. Data are 










95%) (Figure 2.9). Our future experiments relied exclusively on antigen presentation 
assays, which induced weaker stimulations in the hybridomas compared to the antibody 
mediated stimulations. Therefore, since viability was not a concern even in the strongest 
possible stimulation condition, we elected not to include Bcl2 in our cells to ensure that 
weak signals could be observed.  
2.8 GFP induction is more sensitive than IL-2 secretion 
  We had, thus far, taken several measures to ensure that the hybridomas were 
sensitive to stimulation. However, we had not compared it to other commonly used 
assays, such as measuring IL-2, to confirm that GFP induction in our hybridomas was a 
more authentic readout of stimulation. As described previously, determining the 
concentration of IL-2 in the supernatant provides a bulk measurement of the overall 
stimulation occurring in the well without specifically identifying the stimulated cells. 
Since our hybridomas also secreted IL-2 upon stimulation, we could directly compare 
the sensitivity of both measurements out of the exact well in which the stimulation 
occurred. 
 Two primary ways of measuring IL-2 have been established in the literature. The 
first involves measuring the concentration of IL-2 in the supernatant using an ELISA, 
which is a cell-free system that uses antibodies specific for IL-2 to determine the 
quantity of IL-2 in a given volume [81, 111]. The second assay uses an IL-2-dependent 
cell line (HT-2) onto which the IL-2-containing supernatant can be added [112]. This cell 
line requires IL-2 for survival and proliferation and cell growth can be used to determine 
the concentration of IL-2 in the added supernatant. We compared the amount of 
secreted IL-2 using both the ELISA and the HT-2 cells to the proportion of GFP+ cells 
upon stimulation.  
   We first generated standard curves for both ELISA and the HT-2 cells using 























Figure 2.9 Limited loss in hybridoma viability upon stimulation. Forward 
scatter vs. side scatter plots are depicted for Bcl2- and Bcl2+ hybridomas that were 
either unstimulated or stimulated at the indicated concentration with plate-coated 














evident that the limit of detection for the assay was between 0.5-0.6 ng mL-1 (Figure 
2.10A, left). Below this, the absorbance detected by the spectrophotometer could not 
be distinguished for the different concentrations of IL-2 tested. The sensitivity of the 
HT-2 cells was slightly higher because the limit of detection as determined by the 
spectrophotometer was between 0.1-0.2 ng mL-1 (Figure 2.10B, left). Next, we 
stimulated the iNKT hybridomas using the CD1d-expressing CHB-2.4.4 cells at various 
concentrations of αGC. We then measured the quantity of IL-2 in the supernatant of 
any given well after stimulation using both assays and compared it to the proportion of 
GFP+ cells present in the same well. At low doses of antigen, neither IL-2 measurement 
provided a concentration that was above the limit of detection as determined by the 
respective standard curves (Figure 2.10A, B; right). Therefore, using either assay to 
detect stimulation of the hybridomas at those concentrations of antigen would be 
inconclusive. However, even at low concentrations of antigen, GFP+ cells were readily 
identified. In fact, only when >80% of the cells were GFP+ (at the higher concentrations 
of antigen) could a convincing signal be observed with either IL-2 measurement assay. 
Thus, our system provides a more sensitive readout of stimulated hybridomas than 
measuring IL-2 in the supernatant.  
2.9 Discussion 
   Several different cell-based reporters of stimulation have been detailed in the 
literature. All of them ectopically express constructs in cells that contain binding sites 
for transcription factors activated upon stimulation [85, 113, 114]. After binding, they 
















Figure 2.10 GFP induction in stimulated hybridomas displays greater 
sensitivity than secreted IL-2. A Left, Standard curve for IL-2 concentration 
measurements by ELISA. Right, iNKT hybridomas were stimulated using CD1d+ APCs 
at various concentrations of added αGC lipid. After 18-24 hours, secreted IL-2 in the 
supernatant was measured by ELISA and the induction of GFP was measured in the 
responding hybridomas. Both are plotted as a function of antigen concentration. B Left, 
Standard curve for IL-2 concentration measurements by the HT-2 assay. Right, iNKT 
hybridomas were stimulated using CD1d+ APCs at various concentrations of added 
αGC lipid. After 18-24 hours, secreted IL-2 in the supernatant was determined by 
adding the supernatant to cultures of the IL-2-dependent HT-2 cell line and then 
measuring extent of HT-2 proliferation. Concurrently, the induction of GFP was 
measured in the responding hybridomas. Both are plotted as a function of antigen 








the control of NFAT was lacZ, the gene coding for the bacterial enzyme β-galactosidase 
[115, 116]. Although this reporter system provided a suitable readout, the presence and 
quantity of β-galactosidase had to be inferred based on adding a fluorescent substrate 
and subsequently measuring fluorescence. Another developed reporter system is NFAT 
driving expression of the firefly luciferase [117, 118]. Even though this reporter system 
has been frequently used, one caveat is that the responding cells need to be lysed and 
then assessed for luciferase activity, precluding the investigator from specifically 
identifying the stimulated cells. Thus, both the reporter genes require additional 
processing and in the case of the luciferase reporter, valuable information about the 
responding cells is lost. 
 Using GFP as a reporter gene has several advantages. First, GFP has relatively 
low toxicity when it is expressed [119]. Second, it has a relatively long half-life, allowing 
GFP+ cells to be identified even if they are not actively being stimulated [120]. Third, the 
GFP fluorophore forms naturally upon expression without the need for any substrate 
addition or enzymatic modification [121]. Thus, the GFP fluorescence intensity serves as 
a direct readout of total GFP present within the cell. Lastly, because GFP is contained 
intracellularly, GFP induction in a reporter assay can be used to individually identify the 
stimulated cells [122]. 
 We used a previously reported NFAT-GFP construct [85] and stably expressed 
it in a TCR- T cell hybridoma cell line [68]. Since the hybridomas have been selected for 
loss of TCR, the system is modular by design as any TCR of interest can be 
independently expressed and tested. Although not all the cells became GFP+ initially 
upon TCR expression and stimulation, we increased the sensitivity of the hybridomas in 
three important ways. First, we isolated a clone via limiting dilution that responded 
strongly to TCR-mediated stimulation. Second, we introduced the costimulatory 
molecule CD28 into the hybridomas, which increased the proportion of GFP+ cells by a 
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factor of two when it was engaged in conjunction with the TCR. Lastly, we increased 
the functional avidity of the cells by increasing the TCR levels through the 
overexpression of each of the CD3 subunits. Overall, after all of these improvements, 
the cells responded in a sensitive and dose-dependent manner, with >90% of the cells 
responding in some stimulation conditions. 
 The use of any reporter intrinsically creates a reductionist system. Instead of 
relying on the complex regulatory regions that control the expression of any gene in 
response to a stimulus, the reporter systems frequently use specific transcription factor 
binding sites to drive expression of the reporter gene. This removes the checks and 
balances normally imposed on transcription factors by the genome and other binding 
partners and instead exclusively measures the efficiency of activity of a transcription 
factor in a given stimulation condition. Thus, it is crucial that the interpretations of the 
observations reflect the contrived nature of the system. In our case, we intended to use 
the reporter cell line with the three goals of ensuring a TCR-dependent signal, antigen 
specificity and antigen dependence in the stimulated cells. We confirmed that each of 
the three goals were indeed met. Therefore, we could confidently express unique TCRs 
and assess their reactivities. 
 Over the course of our experiments, we inadvertently noticed that Bcl2 
overexpression can dampen TCR-mediated signals. Several published studies also 
corroborate this finding [123-125]. Interestingly, Bcl2 and several other anti-apoptotic 
proteins in its family not only localize to the mitochondria but also to the ER. Here, 
they have been shown to interact with the IP3 receptor (IP3R) [126]. IP3 is a second 
messenger that is produced during the TCR signaling cascade and binds to the IP3R in 
the ER membrane and promotes calcium release from the ER into the cytosol [72]. 
Consequently, the cytosolic calcium indirectly activates NFAT and triggers its nuclear 
localization. Bcl2 specifically interacts with the IP3R and prevents calcium release into 
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the cytosol, thereby halting the downstream signaling pathway [127, 128]. Therefore, 
not surprisingly, Bcl2 overexpression in our hybridomas also reduced the induction of 
GFP upon stimulation as NFAT was inefficiently entering the nucleus. Of note, not all 
anti-apoptotic Bcl2 family members interact with IP3R in this manner. Bcl-xL does not 
appear to inhibit calcium release from the ER and this has been linked to a lysine to 
aspartic acid mutation in its BH4 domain (Figure 2.11A) [129]. This family member 
does, however, retain its pro-survival functions. Intriguingly, DP thymocytes express 
high levels of the transcription factor RORγt, which in turn drives the expression of Bcl-
xL [130, 131]. Expression of Bcl-xL in DP thymocytes is thought to promote their 
survival and increase the potential for distal V- to J-gene rearrangements [132]. 
Unrelatedly, DP thymocytes have been demonstrated to be exquisitely sensitive to 
stimulation upon interaction with various self-pMHC complexes [59, 133]. It is tempting 
to speculate that Bcl-xL expression allows for the survival of DP thymocytes during 
selection while concurrently maintaining their sensitivity to weak antigens. Furthermore, 
post-selection single positive (SP) thymocytes display a concomitant increase in Bcl2 
levels, perhaps as a way to dampen their self-reactivity upon entry into the periphery 
(Figure 2.11B). In light of this underappreciated role of Bcl2, it is important to 
interpret data obtained from a Bcl2 transgenic mice with caution [134, 135]. Developing 
thymocytes in this setting may not be identical to ones that develop in a wild-type (WT) 
setting when their TCR repertoires or responses are assessed. Future experiments 
should try to address these questions.     
 Comparing the sensitivity of GFP induction in the hybridomas to IL-2 secretion 
by the hybridomas upon stimulation demonstrated that GFP induction is observed at 
lower doses of stimulation. Measuring IL-2 secretion by T cell hybridomas as a readout 
of stimulation remains a popular assay. Yet, our data indicate that such a measurement 





















Figure 2.11 Expression pattern of Bcl2 in thymocytes. A The BH4 domains of 
Bcl2 and Bcl-xL are aligned. The BH4 domain for each protein is identical between 
mouse and human. Identical residues are highlighted in red. The lysine (K) to aspartic 
acid (D) mutation between Bcl2 and Bcl-xL is noted in blue. B Bcl2 levels in various 
thymocyte populations of a C57BL/6 mouse were measured and plotted. Experiment 







for orphan TCRs is relevant in many settings including autoimmunity and cancer [136, 
137]. In many cases, the TCRs may display weak interactions with their targets and 
thereby transmit weak intracellular signals. Our system may provide greater resolution 
and sensitivity when such TCRs are tested compared to conventional assays. 
Additionally, as a screening tool, multiple TCRs independently expressed in the reporter 
bearing hybridomas can be simultaneously tested for their unique reactivities, allowing 
































THE INTRINSIC BIAS OF THE αβ TCR FOR MHC 
 αβ T cells in the periphery primarily express TCRs that are MHC-restricted. Yet, 
whether this restriction is an intrinsic feature of TCRs remains a controversial topic. 
Two leading hypotheses have been proposed to explain MHC-restriction [138, 139]. 
The first hypothesis is the selection hypothesis, which states that TCRs, much like 
antibodies, intrinsically have the potential to interact with various surface ligands – MHC 
and non-MHC alike [135]. However, thymic selection imposes MHC-restriction chiefly 
due to the actions of the coreceptors, which serve as gatekeepers by culling non-MHC-
restricted TCRs from the repertoire [140]. The latter hypothesis has been dubbed the 
germline hypothesis, which states that there exists a bias even prior to selection for 
TCRs to interact with MHC molecules. For this bias to exist, residues within the 
germline-encoded regions of the TCR that interact with the MHC molecules had to 
have been positively selected over evolutionary time scales to specifically interact with 
MHC molecules [141-143]. Numerous studies have been published providing evidence 
to support either claim yet no clear consensus has been reached. Moreover, the 
interpretations from the data in many of the previous studies are not always entirely 
straightforward. 
 Many of the studies supporting the selection hypothesis were conducted by 
members of Alfred Singer’s group. This group developed a novel mouse model in which 
both the coreceptors (CD4 and CD8) as well as both the classical MHC molecules 
(MHC-I and MHC-II) were knocked out [134, 135, 140, 144]. In this QuadKO mouse, 
they isolated mature αβ T cells in the periphery bearing TCRs that now recognize 
conformational epitopes instead of linear peptides presented by MHC molecules. 
Although the specificity of these TCRs is irrefutable, the question that remains is the 
frequency at which such TCRs are present in the pre-selection repertoire. One of the 
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reported findings is that αβ T cells in the periphery of a naïve QuadKO mouse have 
significantly higher levels of the surface marker CD44, a protein associated with 
activation and memory [134]. High levels of CD44 on T cells in a non-immunized mouse 
are frequently linked to lymphopenia-induced proliferation (LIP) [145-148]. When there 
are insufficient T cells in the periphery to occupy their allotted space, T cells expand 
due to cytokine and TCR-mediated signals and fill their niche. As a consequence of their 
expansion, the cells acquire higher levels of CD44 despite never having encountered any 
foreign antigen. Thus, the observation that unimmunized QuadKO mice possess T cells 
that are CD44hi could be indicative of LIP caused by fewer than normal cells selected in 
the thymus and entering the periphery. Overall, one further implication could be that 
although non-MHC-restricted TCRs do exist in the pre-selection repertoire, they are 
relatively infrequent and consequently, only the few T cells bearing selectable non-
MHC-restricted TCRs enter and subsequently, expand in the periphery. A similar 
finding was observed when the CDR1 and CDR2 residues of a specific TCRβ chain were 
randomized in vivo by a different group [149]. The germline hypothesis would predict 
that mutating these residues would abrogate MHC-recognition by these TCRs. Instead, 
T cells with mutant TCRs were selected and became MHC-restricted. However, the 
peripheral T cells expressed high levels of CD44, perhaps also due to LIP. Thus, one 
possible conclusion is that while MHC molecules can tolerate changes to the germline 
CDR residues, they do so inefficiently. These studies highlight the need to understand 
whether non-MHC-restricted TCRs in the pre-selection repertoire represent the rule 
or the exception. 
   On the other hand, studies supporting the germline hypothesis also present 
with their own provisos. Two separate studies interrogated reactivities of DP 
thymocytes from MHC-/- mice and both determined that there exists a bias for MHC 
recognition in the pre-selection TCR repertoire [150, 151]. However, in both studies, 
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the DP cells they interrogated continued to express their coreceptors, thereby 
potentially only allowing the cells bearing MHC-restricted TCRs to respond and 
consequently, biasing their conclusions. One other recurring caveat with studies 
supporting the germline hypothesis is the continued use of post-selected MHC-
restricted TCRs [81, 152-154]. Solved structures of the entire TCR/ligand complex by 
necessity require a known ligand for the TCR. Not surprisingly, thus far, all the TCRs 
for which the complex structures have been solved are MHC-restricted, perhaps 
enriching for a specific set of TCRs. Therefore, conclusions from these structures about 
conserved modes of recognition through ‘codons’ by TCRs may extend only as far as 
the subset of MHC-restricted TCRs as opposed to the entire world of TCRs, which 
may possess a large frequency of non-MHC-restricted TCRs as well. Indeed, one 
conserved tyrosine residue in the CDR2 region of a specific Vβ chain proposed to be 
required for efficient interaction with MHC molecules was also demonstrated to be 
critical for interaction with a non-MHC ligand in a different TCR [81, 135], suggesting 
that the tyrosine is important for ligand recognition, not exclusively MHC recognition.  
One study generated retrogenic mice using unselected TCRα chains and 
concluded that approximately 15% of the pre-selection repertoire was restricted to the 
MHC molecules present in a C57BL/6 mouse [155]. However, the TCRβ chains used in 
these mice originated from post-selected MHC-restricted αβ T cells, making it unclear 
whether the resulting TCRαβ pairs could truly be representative of the pre-selection 
repertoire. Previous work by our group has also used post-selected MHC-restricted 
TCRs to draw conclusions regarding any potential intrinsic bias within the TCR for 
MHC molecules [81, 143, 152, 156]. Yet, it is important to note that the nature of 
these MHC-restricted TCRs could have biased any observed results by primarily yielding 
MHC-restricted responses. Therefore, the bias of the true pre-selection TCR 
repertoire for MHC has not yet been tested in a formal approach. 
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3.1 Unselected TCRα libraries are diverse 
 Having established a sensitive in vitro reporter hybridoma system into which we 
could introduce various TCRs of interest, we sought to express an unselected 
repertoire of TCRs and then test the reactivities of the cells bearing these receptors. 
Additionally, the system was amenable to screening libraries of TCRs because each cell 
bearing a given TCR responded independently of other neighboring cells bearing 
different TCRs. Thus, we could express libraries of unselected TCRs in the hybridomas, 
subject them to various stimulation conditions and rapidly determine their reactivities. 
Importantly, though, it was key that the TCRs we planned to express truly belonged to 
the pre-selection repertoire. For this purpose, we elected to take advantage of the 
TCRα-/- mouse [157]. In this strain, the constant gene in the TCRα locus (TRAC) was 
disrupted by introducing a neomycin cassette. Cells can still undergo TCRα locus 
rearrangements at the developmentally appropriate stage and then be transcribed but 
since all the rearrangements are spliced to TRAC, the translated protein is unstable and 
promptly degraded. Consequently, despite a functional TCRβ chain, the DP thymocytes 
in this mouse never express functional αβ TCRs that can be fully interrogated for 
selection against any ligand. Therefore, TCRs from this mouse accurately sample the 
pre-selection repertoire.  
Since the overall number of unique TCR sequences has been estimated to 
exceed 1015 [5], we elected to generate TCRα libraries that we could pair to fixed 
TCRβ chains in our hybridomas. This would dramatically restrict the number of TCRs 
we would be interrogating and make the experiments more practical. Upon purifying 
DP thymocytes from a TCRα-/- thymus, we isolated the RNA from the cells and first 
generated the TCRα libraries by selecting 5 different TRAV genes – TRAV5, TRAV6, 
TRAV7, TRAV9, and TRAV14. This was accomplished by using forward primers that 
annealed to the leader regions of each of the genes and a common reverse primer that 
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annealed to a region upstream of where TRAC was disrupted (Figure 3.1A). Each of 
these amplification products could be considered a library even though each product 
used the same TRAV gene because the TRAJ genes with which they rearranged and the 
subsequent junctions they created were both diverse (Figure 3.1B). The libraries were 
then independently cloned into a MSCV-based retroviral plasmid directly upstream of an 
unperturbed TRAC gene. Importantly, this ensured that upon infecting the hybridomas 
with the resultant virions, functional rearrangements could now be appropriately 
expressed. In this manner, we cloned 5 independent libraries composed of unselected 
TCRα chains into retroviral plasmids. 
We next deep sequenced the cloned TCRα libraries to determine the total 
diversity of the repertoire we would be interrogating. The libraries were each similarly 
diverse and altogether >5x104 unique sequences were identified (Figure 3.2, top). All 
the functional (non-pseudogene) TRAJ genes were represented in the rearrangements 
as well. Not surprisingly, approximately 2/3 of the rearrangements coded for non-
productive proteins. Since the rearrangements were obtained from an unselected TCRα 
repertoire, there was no enrichment for functional rearrangements. Despite the fact 
that these rearrangements were now positioned directly upstream of the natural 
undisrupted TRAC gene, as would have occurred in vivo, these rearrangements would 
never produce functional proteins. Upon condensing for rearrangements coding for 
functional proteins, we were left with approximately 1.6x104 unique rearrangements 
(Figure 3.2, bottom). The CDR3 lengths for each TRAV library were normally 
distributed centered at a length of 14 residues (Figure 3.3). Thus, we generated a 
diverse library of unselected TCRα rearrangements that we could express in 
hybridomas bearing fixed TCRβ chains and the reactivities of the hybridomas subjected 








Figure 3.1 TCRα rearrangements can be isolated from TCRα-/- DP 
thymocytes. A Cartoon representation of TCRα cDNA molecules after reverse 
transcription of RNA isolated from TCRα-/- DP thymocytes. The TRAC gene is 
disrupted by the presence of the pgk-neo cassette. The arrows represent where the 
primers for generating TRAV libraries anneal. The forward primers anneal to the leader 
sequences for each of the indicated TRAV genes and contain a BglII site for downstream 
cloning. The reverse primer anneals to TRAC upstream of the pgk-neo insertion and 
contains a BspEI site for downstream cloning. B PCR products for each of the 
generated TRAV libraries using the aforementioned primers. TRAV5 contains multiple 
bands due to the forward primer annealing to multiple TRAV5 family member genes 












Figure 3.2 TRAV libraries from TCRα-/- DP thymocytes are diverse. Top, 
TRAV PCR products were independently cloned into acceptor retroviral plasmids to 
generate five distinct plasmid libraries. The total sequences present in each library are 
depicted, with >5x104 overall sequences. Bottom, Only the sequences in each of the 
plasmid libraries coding for a functional TCRα chain are depicted, with ~1.6x104 overall 
sequences. In each plot, each circle represents a unique sequence. The size of the circle 
corresponds to the number of times the sequence was observed in our data. Lastly, the 







































Figure 3.3 CDR3 lengths in TRAV libraries are normally distributed. The 
CDR3 amino acid length distributions are depicted for the functional sequences present 
in each TRAV library. Between 2000 and 4000 sequences were analyzed for each library.  
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3.2 Post-selected TCRβ chains impart MHC reactivity 
 We had created five independent TCRα libraries with a total of ~1.6x104 
rearrangements obtained from an unselected TCR repertoire. Each of these libraries 
would now need to be expressed in the hybridomas and paired to specific TCRβ chains. 
Next, we could interrogate the reactivities of the cells expressing the libraries when co-
cultured with APCs and determine whether MHC was frequently targeted by these 
TCRs or not.  
It was unclear whether our strategy would produce any observable reactivity by 
the hybridomas when co-cultured with APCs, whether against MHC or any other 
surface ligand. Thus, to validate our approach, we first elected to pair the TCRα 
libraries with post-selected MHC-restricted TCRβ chains. Since these TCRβ chains had 
already been selected on MHC, we predicted that hybridomas expressing such TCRβ 
chains may be predisposed to respond to MHC in an antigen presentation assay by 
upregulating GFP. We could test this hypothesis by co-culturing the hybridomas with 
APCs expressing both MHC molecules and numerous other surface ligands and 
determine the proportion of responding cells by identifying the hybridomas that induce 
GFP in this condition. We could subsequently determine the proportion of cells 
responding specifically to pMHC ligands by adding antibodies blocking MHC interaction 
by TCRs and identifying the hybridomas that continue to induce GFP. In this manner, 
we could determine two things. First, we would be able to verify that despite never 
having undergone any selection, the TCRα libraries we were testing did have the 
potential to interact with surface ligands and transduce a signal into the cells. And 
second, we could determine the frequency with which cells expressing the TCRα 
libraries would react and respond in a MHC-dependent manner.  
We selected three different TCRβ chains to test our hypothesis – the 75-55β, 
the YAe5-62.8β, and the DO-11.10β chains. Both the 75-55β and the YAe5-62.8β chains 
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originate from TCRs that were selected in a genetically manipulated mouse in which all 
the MHC-II molecules were associated with a single peptide (I-Ab-SP mouse) [87]. In 
this case, all MHC-II (I-Ab) molecules in the mouse were linked to the Eα52-68 peptide. 
The mice were immunized with the aforementioned 3K peptide and the responding 
CD4+ αβ T cells were isolated. Interestingly, although the T cells were selected for their 
ability to respond to the 3K/I-Ab complex, the TCRs expressed by these T cells were 
also discovered to be poly-reactive to various MHC haplotypes and MHC classes [158]. 
Indeed, the CDR3 region of the YAe5-62.8β chain was later discovered to promote the 
broad alloreactivity [159]. Therefore, these two TCRβ chains would serve as a positive 
control for measuring MHC reactivity within the hybridomas. The DO-11.10β chain 
instead originates from a TCR that has a defined specificity directed to I-Ab or I-Ad 
MHC-II molecules presenting the 323-339 peptide fragment derived from chicken 
ovalbumin [27, 81]. This chain would be more restricted in its ability to respond to 
various pMHC (or other) ligands and perhaps be more indicative of what is naturally 
observed in experiments involving most TCRβ chains that did not develop in a I-Ab-SP 
mouse.   
 We independently expressed the three TCRβ chains in the hybridomas and then 
paired each of the TCRβ chains with each of the TRAV libraries to generate hybridomas 
bearing 15 different TCR libraries that could be separately interrogated for their 
reactivities. Additionally, the hybridomas were all sorted to ensure equivalent TCR 
levels. The hybridomas were then cultured with the CHB-2.4.4 H-2b-bearing APCs 
either with isotype antibodies or antibodies specifically blocking TCR interactions with 
MHC molecules. After 18-24 hours of stimulation, we isolated the hybridomas from 
every single condition and assessed the induction of GFP in each setting. 
 The hybridomas bearing the promiscuous 75-55β and YAe5-62.8β chains paired 
to the unselected TCRα libraries responded strongly when cultured with the APCs, 
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irrespective of the TRAV libraries that were interrogated (Figure 3.4, top and 
middle). For example, approximately 85% of the hybridomas expressing the TRAV6 
library paired to the 75-55β chain responded to the APCs in the presence of the 
isotype antibodies in this stimulation assay. TRAV6/YAe5-62.8β expressing hybridomas 
also responded the strongest of all the hybridomas that bear libraries paired to the 
YAe5-62.8β chain. The responses by the hybridomas were characteristic to the specific 
TRAV library expressed by each of them. Importantly, when MHC blocking antibodies 
were instead added to the stimulation assay, the responses by the hybridomas were 
significantly inhibited regardless of the TRAV library that the hybridomas expressed. In 
some cases, such as when hybridomas expressing the TRAV7 library paired to the 75-
55β chain were stimulated in the presence or not of MHC blocking antibodies, 
approximately 90% of the observed response was abrogated when MHC blocking 
antibodies were included in the culture. Thus, hybridomas expressing TRAV libraries 
paired to the poly-reactive TCRβ chains responded strongly for all TRAV libraries 
tested and were largely MHC-restricted in their responses.  
 When the DO-11.10β chain expressing hybridomas expressing the various TRAV 
libraries were stimulated in the same conditions, the observed responses were far more 
limited. Hybridomas expressing four of the TRAV libraries (TRAV6, TRAV7, TRAV9 and 
TRAV14) did not respond to the APCs in a MHC-restricted or MHC-independent 
manner. However, hybridomas expressing the TRAV5 library paired to the DO-11.10β 
chain responded strongly (approximately 16% of the hybridomas responded) to the 
APCs and this entire response was directed at pMHC ligands present on the surfaces of 
the APCs (Figure 3.4, bottom). Interestingly, the original DO-11.10α chain in the DO-
11.10 αβ TCR that is pMHC-specific is also a TRAV5 rearrangement product. Taken as 
a whole, it appears that TCRβ chains derived from poly-reactive TCRs maintain their 























Figure 3.4 Post-selected TCRβ chains impose MHC-restriction when paired 
to unselected TCRα chains. Each of the five TRAV libraries was independently 
expressed in hybridomas expressing one of either the 75-55β, the YAe5-62.8β, or the 
DO-11.10β chains. The resulting hybridomas were then co-cultured with CHB-2.4.4 
APCs in the presence of isotype or MHC blocking antibodies and the proportion of 
GFP+ cells was assessed. Representative plots for each of the conditions tested are 
displayed on the left. The data from two independent experiments are summarized on 
the right with red representing the isotype antibody condition and blue representing the 
MHC blocking antibody condition (*P < 0.05, **P < 0.01, and ***P < 0.001 by multiple 








Further, the MHC-restriction of these TCRβ chains derived from MHC-restricted TCRs 
is also maintained despite no inherent ligand preference displayed by the TCRα libraries 
with which they are paired.  By contrast, TCRβ chains derived from TCRs that display a 
defined specificity prefer particular TCRα chains with which they can pair and interact 
with a ligand. In the case of the DO-11.10 TCRβ chain, only the cells expressing the 
TRAV5 library responded to the APCs, which may reveal that TRAV5 chains are better 
suited to produce a reactivity with the DO-11.10β than chains from other TRAV genes. 
Despite this TRAV choice restriction, the observed responses were MHC-restricted, 
suggesting yet again that the nature of the TCRβ chains may influence the ligand with 
which a complete αβ TCR may interact. 
3.3 Frequent CDR3β sequences are public and short 
 The previous experiments using the post-selected TCRβ chains indicated that 
the nature and composition of the TCRβ chains strongly determines the reactivities of 
the complete αβ TCR. All of the TCRβ chains we had tested thus far were 
rearrangement products using the TRBV13-2 V-gene. Yet, when expressed in 
hybridomas and paired to TCRα libraries, the observed responses by the various 
hybridomas could be directly linked to the nature of a given TCRβ chain. Since the 
CDR1 and CDR2 regions were shared between all three TCRβ chains, we predicted 
that the nature of the CDR3 region imbued the TCRβ chain with greater or reduced 
reactivity to pMHC ligands. Since we were interested in studying the pre-selection 
repertoire, we wondered whether CDR3 regions with greater reactivity to pMHC 
ligands were common or infrequent in the pre-selection TCRβ repertoire. Alternatively, 
the question could also be phrased as follows – do common TCRβ rearrangements in 
the pre-selection repertoire display a bias for interacting with pMHC ligands? We could 
determine this by first identifying the most common TCRβ rearrangements, expressing 
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them in the hybridomas, pairing them to the TCRα libraries and then interrogating the 
hybridomas’ reactivities when cultured with APCs. 
 To determine what the most common TCRβ rearrangements were in the pre-
selection repertoire, we first determined the most popular TRBV gene used in the pre-
selection repertoire. Since antibodies specific for many of the TRBV gene products are 
available, we conducted intracellular flow cytometry using these antibodies to identify 
the TRBV gene usage in pre-selection thymocytes (Figure 3.5A). In a WT C57BL/6 
mouse, the pre-selection thymocytes are defined as DP CD69- CD5- CD24+ cells. These 
cells are actively undergoing TCRα rearrangements but have yet to express a productive 
rearrangement that has been interrogated for selection. When such cells were 
intracellularly stained with the different TRBV-specific antibodies, we observed roughly 
equal usage of each of the tested TRBV genes. Two of the antibodies (TRBV12 and 
TRBV13), though, each stained approximately twice as many thymocytes as the other 
antibodies. Interestingly, both TRBV targets are composed of two genes that cannot be 
serologically distinguished, although the individual contributions of the genes to the 
overall usage is not known. To confirm whether the TRBV gene distribution was similar 
in a true pre-selection repertoire, we also assessed TRBV gene usage in the thymus via 
intracellular staining of a TCRα-/- mouse, since all DP cells in this strain are no different 
than the CD69- CD5- CD24+ DP cells in a WT mouse. Indeed, the DP thymocytes in 
TCRα-/- mice also displayed a similar TRBV usage, with TRBV12 and TRBV13 genes 
being rearranged twice as frequently as the other genes in the pre-selection repertoire.  
 Since TRBV12 and TRBV13 rearrangements were most frequently observed, the 
most common rearrangements involving the genes coding for the two products could 
be considered the most common rearrangements interrogated for selection in the 
thymus. By deep sequencing the TRBV12 and TRBV13 rearrangements from DP 






Figure 3.5 TCRβ repertoire of TCRα-/- DP thymocytes. A TRBV usage in 
C57BL/6 and TCRα-/- DP thymocytes as determined by intracellular staining using 
antibodies targeting the indicated TRBV proteins. B Summary of TRBJ gene usage within 
TRBV13-2 rearrangements from three independent TCRα-/- DP thymocyte samples 
(mean ± s.d.). C CDR3 amino acid length distribution for all TRBV13-2/TRBJ2-7 
rearrangements from the 3 TCRα-/- samples (mean ± s.d.). D The amino acid CDR3 
sequences for the most frequently observed TRBV13-2 rearrangements. The 
proportions correspond to the frequency with which the rearrangement is observed 

















them in vitro. However, we opted to sequence only TRBV13 rearrangements because 
the TRBV12 proteins have been demonstrated to interact with mouse mammary tumor 
virus (MMTV) superantigens and may provide spurious results in our in vitro system 
[160]. 
 We isolated DP thymocytes from three different TCRα-/- mice and amplified 
TRBV13 rearrangements by PCR before submitting these samples for deep sequencing. 
When the sequences were analyzed, it became clear in each of the samples that >70% 
of the rearrangements used the TRBV13-2 gene as opposed to the TRBV13-1 gene. 
Additionally, when the J-gene (TRBJ) distribution was analyzed across all sequences, our 
data corroborated previous findings that the TRBJ2 genes were used more frequently 
than the TRBJ1 genes (Figure 3.5B). This has been attributed to the genomic location 
of the TRBD1 gene permitting it to recombine with both the TRBJ1 and TRBJ2 genes 
while the location of the TRBD2 gene restricts its recombinations with the TRBJ2 genes 
only in order to maintain the 12/23 rule of recombination [47, 50]. In particular, 
approximately 20% of the sequences involved a TRBJ2-7 rearrangement, making it the 
most commonly used TRBJ gene. Within the sequences using TRBJ2-7, various CDR3 
lengths were represented that were normally distributed around a length of 14 residues 
(Figure 3.5C). 
 We next identified three sequences that were the most frequent 
rearrangements found in our data (Figure 3.5D). Not surprisingly, each of these 
sequences used the TRBV13-2 and TRBJ2-7 genes. Besides being the rearrangements 
that were most frequently observed, they were also found to be the most common 
rearrangements in each of the three samples we had sequenced. Consequently, it is 
likely that in any murine thymus of C57BL/6 background, these three rearrangements 
would be present frequently in pre-selection DP thymocytes and would thereby, be 
more frequently interrogated for selection than any other TCRβ rearrangements.  
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 Lastly, the three rearrangements all possessed much shorter CDR3 lengths than 
~90% of the sequences we had analyzed. These sequences all lacked an identifiable 
TRBD gene, a rare phenomenon frequently precluded by the beyond 12/23 rule [161]. 
Additionally, the CDR3 regions for each were primarily composed of germline 
contributions by the TRBV13-2 and TRBJ2-7 genes with no/few identifiable non-
templated nucleotides. Thus, frequently observed rearrangements in a murine thymus 
appear to possess short CDR3 regions that are mostly germline-encoded. We next 
expressed the three rearrangements in our hybridomas with the goal of testing the 
ability of frequent and unselected TCRβ chains to engender MHC reactivity when paired 
to unselected TCRα libraries. 
3.4 Hybridomas expressing unselected TCRs weakly react to APCs 
 Upon having expressed the three TCRβ chains and pairing them to the TCRα 
libraries in the hybridomas, we co-cultured the hybridomas with APCs bearing the H-2b 
(CHB-2.4.4) or the H-2d (BALB/C MutuDC) MHC haplotypes in the presence of isotype 
or MHC blocking antibodies. We named the three TCRβ chains 13-2_1β, 13-2_3β, and 
13-2_4β. When stimulated by H-2b bearing APCs, few of the hybridomas expressing the 
TCRα libraries paired to any of the TCRβ chains responded (Figure 3.6A). None of 
the hybridomas bearing the 13-2_1β chain responded to these APCs. Yet, hybridomas 
expressing the TRAV7 library paired to either 13-2_3β or 13-2_4β responded to the 
APCs in the presence of an isotype antibody. Interestingly, the reactivity of the 
TRAV7/13-2_3β and TRAV7/13-2_4β hybridomas was inhibited in the presence of MHC 
blocking antibodies, suggesting that their original responses were primarily directed 
against pMHC ligands. Overall, the tested hybridomas did not strongly react to APCs 
bearing numerous surface ligands (including pMHC molecules).  
 Culturing the same hybridomas expressing the various unselected TCR libraries 

























Figure 3.6 Coreceptors strengthen intrinsic specificity of TCRs for MHC. A 
Each of the TRAV libraries was independently expressed in hybridomas bearing one of 
the three frequently occurring TCRβ chains. The resulting hybridomas were co-cultured 
with CHB-2.4.4 cells for 18-24 hours and the proportion of GFP+ cells in each 
stimulation condition was assessed and plotted. B CD4 was introduced into each of the 
distinct hybridoma populations from A and the resulting hybridomas were co-cultured 
with CHB-2.4.4 cells for 18-24 hours and the proportion of GFP+ cells in each 
stimulation condition was assessed and plotted. C Table illustrating at what position of 
the 13-2_3β chain a tryptophan (W in red) was introduced to create a novel TCRβ 
chain. D Each of the TRAV libraries was independently expressed in CD4- (left) or 
CD4+ (right) hybridomas bearing the engineered 13-2_3W TCRβ chain. The resulting 
hybridomas were co-cultured with CHB-2.4.4 cells for 18-24 hours and the proportion 
of GFP+ cells in each stimulation condition was assessed and plotted. Red represents the 
isotype antibody condition and blue represents the MHC-blocking antibody condition. 
Each experiment was repeated two independent times with two replicates per 
condition in a given experiment (*P < 0.05, **P < 0.01, and ***P < 0.001 by multiple 
























Figure 3.7 Coreceptors strengthen intrinsic specificity of TCRs for H-2d 
MHC. A Each of the TRAV libraries was independently expressed in hybridomas 
bearing one of the three frequently occurring TCRβ chains. The resulting hybridomas 
were co-cultured with BALB/c MutuDC cells for 18-24 hours and the proportion of 
GFP+ cells in each stimulation condition was assessed and plotted. B CD4 was 
introduced into each of the distinct hybridoma populations from A and the resulting 
hybridomas were co-cultured with BALB/c MutuDC cells for 18-24 hours and the 
proportion of GFP+ cells in each stimulation condition was assessed and plotted. C Each 
of the TRAV libraries was independently expressed in CD4- (left) or CD4+ (right) 
hybridomas bearing the engineered 13-2_3W TCRβ chain. The resulting hybridomas 
were co-cultured with BALB/c MutuDC cells for 18-24 hours and the proportion of 
GFP+ cells in each stimulation condition was assessed and plotted. Red represents the 
isotype antibody condition and blue represents the MHC-blocking antibody condition. 
Each experiment was repeated two independent times with two replicates per 
condition in a given experiment (*P < 0.05, **P < 0.01, and ***P < 0.001 by multiple 





all the hybridomas expressing the 13-2_1β libraries responded relatively strongly in the 
presence of these APCs while none of the 13-2_3β nor the 13-2_4β expressing 
hybridomas responded. The TRAV9/13-2_1β expressing hybridomas responded 
particularly strongly to the APCs, with approximately 15% of the hybridomas inducing 
GFP in the presence of isotype antibodies. A large portion of each of these responses 
was abrogated in the presence of MHC blocking antibodies, suggesting that the 
observed responses were directed against pMHC ligands. Taken together, the data 
suggest that the responses by the hybridomas expressing these unselected TCRs is 
relatively weak in most cases. Nevertheless, even though the TCRs were never 
previously selected for recognition of any ligand, the few observed responses largely 
targeted pMHC ligands. 
3.5 Coreceptors increase the MHC reactivity of the hybridomas 
 Coreceptors have been demonstrated to increase the affinity of TCRs for their 
pMHC ligands [162-164]. To explore whether coreceptors would also enhance any 
intrinsic reactivities in our system, we introduced a mutated hCD4 molecule in our 
hybridomas. The mutations in this molecule have been previously shown to increase 
affinity of hCD4 for human MHC-II molecules [165]. Previous work by our 
collaborators has shown that in the presence of this high affinity hCD4, murine 
hybridomas expressing MHC-II-restricted TCRs also significantly increase their 
sensitivities to respond to their cognate antigens [166]. 
 We introduced the high affinity coreceptor into each of the hybridomas 
expressing the different combinations of TCRα libraries paired to one of the unselected 
TCRβ chains. When the coreceptor+ hybridomas were now cultured with H-2b APCs, 
hybridomas expressing each of the TCR combinations induced more GFP than their 
counterparts that lacked the coreceptor (Figure 3.6B). In fact, the extent of the 
responses by the CD4+ hybridomas mirrored that of the CD4- hybridomas, except each 
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CD4+ condition displayed a greater magnitude of response. For example, hybridomas 
expressing the TRAV7 library paired to 13-2_3β or 13-2_4β responded to H-2b APCs 
stronger than when the TCRβ chains were paired to any of the other TRAV libraries, 
just as was observed when the hybridomas expressed no coreceptor. The only 
difference was that while only 5% of the hybridomas responded in the absence of 
coreceptor, the responses by hybridomas bearing coreceptors but the same TRAV7 
library were increased to 10% and 17% approximately for the 13-2_3β and the 13-2_4β 
chains, respectively. Similar proportional increases were observed across the board. 
Importantly, the hybridoma responses were completely blocked in the presence of 
MHC blocking antibodies, suggesting once again that these responses were directed at 
pMHC ligands. Hybridomas cultured with APCs bearing the H-2d MHC haplotype 
behaved similarly (Figure 3.7B). Thus, TCRs appear to possess some weak intrinsic 
specificity for pMHC ligands and these interactions are enhanced and strengthened by 
coreceptors.  
3.6 CDR3β hydrophobic motif boosts reactivity of the hybridomas 
 A recent publication determined that the presence of certain CDR3β residues 
more potently generates self-reactive TCRs [167]. Hydrophobic residues specifically at 
positions 6 and 7 within the CDR3β (counting from the conserved cysteine) predispose 
the overall αβ TCR to be more self-reactive. To test this finding in our hybridoma 
system, we sought to use TCRβ chains that possessed this hydrophobic doublet motif. 
However, none of the frequently occurring TCRβ rearrangements we had previously 
tested had this motif within their CDR3 regions. We did notice, though, that one of the 
chains (13-2_3β) had a tyrosine residue at the appropriate position that fit the paradigm. 
By introducing another hydrophobic residue (a tryptophan) directly N-terminal to the 
tyrosine, we would be able to recreate a hydrophobic doublet in one of the chains and 
test its self-reactivity (Figure 3.6C). We named this TCRβ chain 13-2_3Wβ. 
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Additionally, we would be able to compare the reactivities of a TCRβ chain with no 
hydrophobic residues (13-2_1β), with only one hydrophobic residue (13-2_3β) and with 
both hydrophobic residues (13-2_3Wβ) to determine the extent to which the number 
of hydrophobic residues affected the reactivities. 
 Hybridomas expressing the 13-2_3Wβ and each of the TRAV libraries responded 
strongly in the presence of H-2b APCs (Figure 3.6D). Once again, more TRAV7 library 
expressing hybridomas responded than the hybridomas expressing other TRAV 
libraries. Nevertheless, the responses by all the different library expressing hybridomas 
was greater than either the 13-2_1β or the 13-2_3β expressing hybridomas. 
Importantly, these responses were MHC-restricted because they were largely abrogated 
in the presence of MHC blocking antibodies. Introducing the coreceptor further 
boosted the responsiveness of each of the hybridomas where in the case of some 
libraries, >20% of the hybridomas were responding. All of the responses were greater 
than those observed in the coreceptor expressing 13-2_1β or 13-2_3β counterpart 
hybridomas. Each of these responses was also completely inhibited when MHC blocking 
antibodies were added to the culture. Similar, albeit reduced, responses were observed 
when the hybridomas were cultured with H-2d expressing APCs (Figure 3.7C). Thus, a 
hydrophobic doublet within the CDR3β does appear to increase self-reactivity but in a 
pMHC-specific manner. 
3.7 Sorting the GFP+ hybridomas enriches for their reactivities 
    Even though the hybridomas were being stimulated in a pMHC-specific 
manner, it was unclear whether these reactivities were stochastic or not. In other 
words, if the GFP+ hybridomas in response to a certain stimulation were sorted, rested, 
and restimulated in the same conditions, would more cells respond or would the 
proportion of responding cells remain unchanged? If the former, then the sorted cells 
maintained their specificities and the process of sorting enriched for responding cells. If 
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the latter, then cells stimulated in this manner were stochastically inducing GFP in a 
non-specific manner. 
 Since the 13-2_4β hybridomas bearing the coreceptor responded strongly to 
stimulation by H-2b APCs in a pMHC-specific manner, we sorted the GFP+ cells bearing 
this TCRβ chain and each of TRAV libraries when cultured with H-2b APCs and isotype 
antibodies. As a negative control, we also sorted the GFP- cells from the same 
stimulation to determine whether they remained GFP- upon restimulation. Once the 
cells returned to their baseline GFP- status, we restimulated the cells using the same H-
2b APCs we used to initially stimulate them. Indeed, we observed more GFP+ cells when 
each of the TRAV library expressing hybridomas were restimulated compared to the 
initial stimulation (Figure 3.8). Furthermore, all of these reactivities were inhibited 
when MHC blocking antibodies were added to the culture. For example, while only 
~15% of the TRAV7 library hybridomas initially responded in a pMHC-specific manner 
to H-2b APCs, ~37% of the GFP+ sorted and restimulated hybridomas responded in a 
pMHC-specific manner. By contrast, the GFP- sorted hybridomas remained GFP- even 
upon restimulation with H-2b APCs, suggesting that these cells do not bear TCRs with 
cognate ligands expressed on the APCs. Thus, the hybridoma reactivities are specific to 
certain ligands and not stochastic. 
3.8 Single cell clones display distinct response profiles 
 Although there was an enrichment observed in the proportion of responding 
cells in the sort and restimulation strategy described in the previous section, it was 
unclear to us as to why the enrichment was relatively poor. Even though GFP+ cells 
were sorted with high purity, at most only ~40% of the sorted hybridomas responded in 
the restimulation conditions. We decided to explore the reasons for this observation. 
 We employed two approaches to address this issue. In the first approach, since 

























Figure 3.8 Hybridomas reactivities can be enriched upon sorting GFP+ cells. 
The CD4+ hybridomas expressing each of the TRAV libraries paired to TRBV13-2_4β 
were co-cultured with CHB-2.4.4 for 18-24 hours. The GFP+ and GFP- cells in each 
stimulation condition were independently sorted and placed in culture. All the sorted 
hybridomas were then restimulated by CHB-2.4.4 cells in the presence of isotype or 
MHC-blocking antibodies and proportion of GFP+ cells in each stimulation condition 
was assessed. Data are representative of two independent experiments with two 













clones by limiting dilution. Each of these clones would presumably express a TCR that 
has the potential to interact with pMHC ligands on APCs and cause the cell in which it 
is expressed to be stimulated. This is because the bulk population was sorted for its 
ability to react to the same APCs and the responses in the restimulations were 
completely pMHC-specific. If instead only ~40% of the clones responded in this 
restimulation assay, that would suggest that the sort was not as pure as anticipated 
because ~60% of the clones instead possess a TCR that does not interact with pMHC 
ligands. If all of the clones were capable of responding upon restimulation, then the 
more likely explanation was that the conditions in which the bulk population was being 
stimulated were not ideal for each of the cells to properly respond. In the second 
approach, we decided to sort the GFP+ cells a second time after restimulation, rest 
them, and then stimulate the cells a third time in the same conditions to determine 
whether there was any additional enrichment of GFP+ cells. For both approaches we 
proceeded with the bulk GFP+ sorted TRAV7/13-2_4β hybridomas. 
 We generated 89 independent clones by limiting dilution that each possessed a 
TRAV7 chain paired to the 13-2_4β chain. After culturing each of these clones with H-
2b APCs, we observed a wide range of GFP inductions within the cells. A few of the 
tested clones responded weakly (~10-20% of the cells became GFP+) while a few others 
responded strongly (>75% of the cells became GFP+) (Figure 3.9A). Overall, the 
median proportion of GFP+ cells for all the clones was ~55%. When MHC blocking 
antibodies were added to the culture, the responses were significantly inhibited and the 
median proportion of GFP+ cells for all the clones was reduced to ~9%. Indeed, when 
normalized to the proportion of responding cells, ~75% of the responses for all the 
clones were inhibited by the addition of MHC blocking antibodies (Figure 3.9B). Thus, 
almost all of the tested clones responded to stimulation, indicating that the sort was not 
























Figure 3.9 Density of cognate pMHC complexes on APCs influences extent 
of GFP induction in responding hybridomas. A 89 different TRAV7/13-2_4β 
clones were cultured with CHB-2.4.4 cells with either isotype or MHC blocking 
antibodies added to the culture and the proportion of GFP+ cells was assessed in each 
stimulation condition. B The normalized proportion of response inhibition in the 
presence of MHC blocking antibodies is plotted for each of the 89 clones. C Bulk 
TRAV7/13-2_4β hybridomas were sorted a second time for GFP+ cells and then 
subsequently, restimulated a third time with CHB-2.4.4 cells in the presence of isotype 
or MHC blocking antibodies. Each clone was stimulated in one experiment with two 











We hypothesize that this is observed due to the density of the particular pMHC ligand 
for which the TCR expressed by each clone is specific. 
 We next sorted the GFP+ cells from the initial restimulation to obtain a 
population that had been sorted twice for its reactivity to the H-2b APCs (Figure 
3.9C). Stimulating this population in the same condition did further enrich the GFP+ 
cells to approximately 70% of the overall population. However, this response was not 
completely inhibited in the presence of MHC blocking antibodies but rather only 
reduced to ~25%. Thus, multiple sorts do lead to increased enrichment of GFP+ cells 
upon restimulation in the presence of isotype antibodies. Yet, the sorted cells could 
now be enriched for TCRs that recognize high density pMHC ligands on the APCs and 
the concentration of blocking antibodies used in the restimulation was likely insufficient 
to completely block the responses.      
3.9 Cross-species conservation of TCR specificity for MHC 
  TCR genes arose early after the divergence between jawed and jawless 
vertebrates approximately 450 million years ago. Jawed vertebrates (gnathostomes) 
possess the genes involved in mediating recombination along with both TCR and 
immunoglobulin genes [3, 168]. However, due to numerous speciation events and 
further divergence within jawed vertebrates, the TCR gene sequences are not well 
conserved across species [169-171]. Overall, when TCR gene sequences from various 
distantly related species are aligned, there is only 20-30% observed sequence similarity. 
Despite this, some key residues are found to be repeatedly conserved in the CDR2 
regions of certain TCRβ genes in many species. A previous study determined that two 
tyrosine residues in the CDR2 of murine TRBV13-2 that were critical for proper TCR 
interactions with pMHC molecules were also conserved in TRBV gene homologs in frog 
(Xenopus laevis), shark (Heterodontus francisci), and trout (Oncorhynchus mykiss) [143]. 
Further, when chimeric TCRβ chains were created with the TRBV13-2 region 
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completely replaced by the homologous genes originating from each of the three 
species, reactivity to mouse MHC molecules was continued to be observed. 
Surprisingly, mutating the tyrosine residues in the chimeric TCRs also abolished 
responses, just as was observed in murine TCRs. Since the TCRβ chain used in the 
previous experiments was the post-selected DO-11.10β, we wondered whether 
unselected chimeric TCRβ chains paired to unselected TCRα libraries in hybridomas 
would also generate reactivities to MHC. We proceeded to test our hypothesis using 
the 13-2_3Wβ and the 13-2_4β. 
 As was previously described, we independently replaced the entire TRBV13-2 
coding sequence upstream of the CDR3 in both 13-2_3Wβ and 13-2_4β chains with the 
TRBV2 gene originating from frog, Vβ3-Hf73 gene originating from shark, and the 
TRBV8S2 gene originating from trout (Figure 3.10A). In this manner, we had now 
generated six different chimeric TCRβ chains. Importantly, the entire sequence 
downstream of the conserved cysteine marking the beginning of the CDR3 remained of 
murine origin for two reasons. Firstly, the role of the CDR3β in these chimeric TCRs 
during stimulations could be assessed and directly compared to experiments conducted 
using the murine TRBV13-2 gene fragment. Secondly, maintaining the murine TRBC 
coding sequence allowed for appropriate expression and pairing of each of these chains 
in the murine hybridomas. 
 We expressed each of these chains separately in the CD4+ hybridomas and then 
paired them to each of the TRAV libraries. TCR expression levels, as determined by 
staining for the TCRβ chain, were not affected in any of the pairings. Next, we cultured 
the hybridomas expressing 30 novel libraries with H-2b APCs in the presence of isotype 
or MHC blocking antibodies. When the three 13-2_3Wβ variant libraries were tested, 
the hybridomas expressing these libraries responded strongly in the presence of H-2b 




Figure 3.10 TCRs with 13-2_3Wβ display xenoreactivity towards MHC 
molecules. A Cartoon representation of the chimeric TCRβ chains used. B Each of 
the TRAV libraries was independently expressed in CD4+ hybridomas expressing one of 
either the frog TRBV13-2_3Wβ, the shark TRBV13-2_3Wβ or the trout TRBV13-
2_3Wβ. The resulting hybridomas were then co-cultured with CHB-2.4.4 APCs in the 
presence of isotype or MHC blocking antibodies and the proportion of GFP+ cells was 
assessed. Representative plots for each of the conditions tested are displayed on the 
left. The data from two independent experiments with two replicates per condition in a 
given experiment are summarized on the right with red representing the isotype 
antibody condition and blue representing the MHC blocking antibody condition (*P < 
0.05, **P < 0.01, and ***P < 0.001 by multiple paired t-tests without post-test 
correction; error bars are mean ± s.d.). 
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chimeric TCRβ chains than those observed with the natural murine TRBV13-2 chain. 
For example, >50% of the hybridomas expressing either the TRAV6 or the TRAV7 
library paired to the frog 13-2_3Wβ chain turned GFP+ in the presence of the H-2b 
APCs. Only ~20% of the counterpart murine 13-2_3Wβ expressing hybridomas 
responded in the same conditions. Furthermore, these responses were completely 
blocked in the presence of MHC blocking antibodies. Proportionally fewer hybridomas 
expressing the chimeric 13-2_4β chains responded in the same conditions when 
compared to the hybridomas expressing the chimeric 13-2_3Wβ chains (Figure 3.11). 
These results mirrored what was observed when the proportion of GFP+ hybridomas 
expressing the murine 13-2_3Wβ was compared to the proportion of GFP+ hybridomas 
expressing the murine 13-2_4β chain. However, when the responses by the hybridomas 
bearing the chimeric 13-2_4β chains were compared to those by the hybridomas 
expressing the murine 13-2_4β chain, more hybridomas expressing the chimeric TCRβ 
chains responded in most of the tested cases. These responses were MHC-restricted as 
well. Overall, our data indicate that despite the lack of sequence similarity, the modes of 
recognition of MHC by TCRs originating from species that diverged over 400 million 
years ago are conserved. 
3.10 Unselected TCRαβ libraries are MHC-biased 
 Thus far, we had tested the reactivities of hybridomas expressing a fixed TCRβ 
chain paired to diverse TCRα chains. Although the TCRβ chains we identified and used 
in our assays were unselected, specific TCRβ chains can display distinctive biases for 
their ligands. Previous work has determined that specific CDR3β sequences can skew 
the CD4+ or CD8+ lineage choice by developing thymocytes during selection [172]. Our 
observed responses could therefore be directly attributed to our choices of TCRβ 





Figure 3.11 TCRs with 13-2_4β display xenoreactivity towards MHC 
molecules. Each of the TRAV libraries was independently expressed in CD4+ 
hybridomas expressing one of either the frog TRBV13-2_4β, the shark TRBV13-2_4β or 
the trout TRBV13-2_4β. The resulting hybridomas were then co-cultured with CHB-
2.4.4 APCs in the presence of isotype or MHC blocking antibodies and the proportion 
of GFP+ cells was assessed. Representative plots for each of the conditions tested are 
displayed on the left. The data from two independent experiments with two replicates 
per condition in a given experiment are summarized on the right with red representing 
the isotype antibody condition and blue representing the MHC blocking antibody 
condition (*P < 0.05, **P < 0.01, and ***P < 0.001 by multiple paired t-tests without 












 To overcome this potential pitfall, we generated a TCRβ library that we could 
express in the hybridomas and pair to the TCRα libraries. The hybridomas would then 
express even more combinations of TCRs than we had initially tested since multiple 
TCRβ chains would be expressed. Subsequently, the reactivities of all of these 
hybridomas could be tested upon co-culture with H-2b or H-2d APCs in the presence of 
isotype or blocking antibodies. Only if these responses matched what we had previously 
observed with fixed TCRβ chains could our conclusions regarding an intrinsic bias for 
pMHC complexes be extended to a greater proportion of TCRs. We created a 
TRBV13-2 library containing numerous TRBV13-2 rearrangements. Additionally, to 
ensure that this library was also unselected, we once again obtained the rearrangements 
from TCRα-/- DP thymocytes. In this manner, just as the previous fixed TCRβ chains we 
had tested, the library represented TCRβ chains that had never paired to functional 
TCRα chains to be selected by any ligand. 
   Surprisingly, despite having generated numerous novel specificities, 4-12% of 
the hybridomas expressing the TCRβ library paired to the different TCRα libraries 
responded to H-2b APCs (Figure 3.12, top). A priori, there was no guarantee that any 
responses would be observed yet when the TRAV6 library was paired to the TRBV13-2 
library and expressed in the hybridomas, ~12% of the hybridomas responded to ligands 
expressed by the H-2b APCs. When we next assessed whether the observed responses 
were directed at pMHC targets, it became clear that they were because the responses 
for all the libraries tested were completely blocked in the presence of MHC blocking 
antibodies. The responses to H-2d APCs were less pronounced as few of the library 
pairings were able to muster an observable response (Figure 3.13, top). Addition of 









Figure 3.12 TCRβ libraries paired to unselected TCRα libraries interact 
with H-2b MHC molecules. Each of the TRAV libraries was independently expressed 
in CD4- (top) or CD4+ (bottom) hybridomas expressing TRBV13-2 libraries. The 
resulting hybridomas were then co-cultured with CHB-2.4.4 APCs in the presence of 
isotype or MHC blocking antibodies and the proportion of GFP+ cells was assessed. 
Representative plots for each of the conditions tested are displayed on the left. The 
data from two independent experiments with two replicates per condition in a given 
experiment are summarized on the right with red representing the isotype antibody 
condition and blue representing the MHC blocking antibody condition (*P < 0.05, **P < 
0.01, and ***P < 0.001 by multiple paired t-tests without post-test correction; error 


















Figure 3.13 TCRβ libraries paired to unselected TCRα libraries interact 
with H-2d MHC molecules. Each of the TRAV libraries was independently expressed 
in CD4- (top) or CD4+ (bottom) hybridomas expressing TRBV13-2 libraries. The 
resulting hybridomas were then co-cultured with BALB/c MutuDC APCs in the 
presence of isotype or MHC blocking antibodies and the proportion of GFP+ cells was 
assessed. Representative plots for each of the conditions tested are displayed on the 
left. The data from two independent experiments with two replicates per condition in a 
given experiment are summarized on the right with red representing the isotype 
antibody condition and blue representing the MHC blocking antibody condition (*P < 
0.05, **P < 0.01, and ***P < 0.001 by multiple paired t-tests without post-test 













 Introducing CD4 in the any of the hybridomas had previously always increased 
the proportion of responding cells in antigen presentation assays. We asked whether 
CD4 would act similarly in this setting as well (Figure 3.12, bottom). To our surprise, 
each of the hybridoma responses to H-2b APCs was boosted between 3- to 10-fold 
such that although only ~4% of the TRAV5/TRBV13-2 library hybridomas responded 
initially, >40% of the same library hybridomas responded in the presence of CD4. 
Additionally, while the libraries lacking CD4 did not respond strongly to H-2d APCs, 
adding CD4 to the hybridomas increased their responses between 3- to 8-fold where 
11-18% of the hybridomas expressing the different TCRα libraries were turning GFP+ 
(Figure 3.13, bottom). Importantly, the responses observed against H-2b and H-2d 
APCs were entirely MHC-restricted. Thus, our data using the fixed TCRβ chains could 
be generalized to a larger proportion of TCRβ chains. Furthermore, our results 
involving the TRBV13-2 library continue to corroborate our conclusion that TCRs do 
possess intrinsic specificity for pMHC ligands that is augmented by coreceptors. 
3.11 Discussion 
 A diverse αβ TCR repertoire is crucial to be able to mount potent immune 
responses against the myriad pathogens capable of infecting a host [173]. An adult, 
unimmunized mouse has been estimated to possess approximately 6x107 naïve αβ T 
cells in its body at any given time [174]. Even if each of these T cells expressed a unique 
TCR, any given mouse would still be under-sampling its TCR repertoire from the 
theoretical repertoire by a factor >107. In actuality, each T cell clone comprises 
between 5-500 cells, thereby substantially reducing the number of unique T cell 
specificities [175-177]. This is further exacerbated by the fact that the universe of 
foreign antigens far outnumbers the number of clones capable of recognizing distinct 




 A recent publication highlighted how T cells circumvent this seemingly 
insurmountable obstacle. Using decamer peptides where each of the 20 proteogenic 
residues was represented at each position (for a total library size of 9.36x1012 peptides), 
the authors determined that the TCR expressed by a specific CD8+ T cell clone can 
recognize >1x106 different peptides [178]. Such receptor degeneracy is crucial for TCRs 
to fully sample the antigenic landscape when comparatively few unique TCRs exist 
within a host. The TCR interacted with the various pMHC complexes with a wide range 
of affinities. Intriguingly, this TCR recognized two peptides presented by the MHC 
molecule even though the peptides differed from each other at seven of the ten 
positions. If TCRs were not interacting with pMHC molecules in conserved manners, 
this broad cross-reactivity may not have been predicted. In this scenario, TCRs selected 
for interacting with a specific pMHC ligand in the thymus would adopt distinct 
conformations unique to the selecting pMHC ligand and be ill-suited to recognize 
pMHC complexes where the peptide is drastically different. Conserved germline 
interactions between the TCR and MHC molecules may properly orient the TCR to 
provide the initial affinity that can be further modulated based on the nature of the 
peptide and the CDR3 regions. Early TCR/pMHC complex structures hinted at the 
notion that the TCR uses its CDR1/2 loops to orient itself onto the MHC and then 
‘scans’ for peptide compatibility through its CDR3 loops [179]. More recently, 
comparing 10 different structures solved involving the same TCR but distinct pMHC 
complexes confirmed the conservation of TCR germline-mediated interactions with 
MHC molecules in orienting the TCR so it can optimally adapt to the different peptides 
[154]. Altogether, structural and biochemical insights into TCR recognition of pMHC 
ligands seem to support a coevolution between TCR and MHC molecules. 
  Here, we provide further support for the germline hypothesis by using a cell-
based reporter readout system. We introduced unselected TCR libraries into these 
79 
 
cells and were able to test the reactivities of cells expressing >105 unique αβ TCR pairs. 
We observed that although cells expressing this unselected TCR repertoire could have 
the capacity to react to any number of ligands, they primarily reacted to pMHC ligands. 
Moreover, when CD4 was expressed in the cells, a greater proportion of cells 
responded to pMHC ligands, suggesting that while TCRs have an inherent specificity for 
pMHC ligands, this specificity is improved by coreceptors. 
 Two other studies have also tested the bias of the pre-selection TCR repertoire 
for MHC and separately concluded that the TCRs do possess a bias for MHC prior to 
selection [150, 151]. However, it is unclear if either of the studies actually tested 
unselected TCR repertoires. Both studies used DP thymocytes (or hybridomas 
generated from these cells) obtained from MHC-naïve mice. These mice were 
generated by crossing β2m-/- mice (mice lacking MHC-I) with I-Aβ-/- mice (mice lacking 
MHC-II) [180, 181]. Yet, C57BL/6 mice lacking β2m still have the potential to express 
the MHC-I molecule Db on cell surfaces [182]. Additionally, non-classical MHC-I 
molecules such as CD1d and MR1, which usually require β2m to be efficiently expressed 
on cell surfaces, can still traffic to the surface in the absence of β2m [183, 184]. Such 
molecules have also been demonstrated to be able to select classical MHC-restricted 
TCRs in mice that lack classical MHC molecules [185, 186]. With regards to MHC-II, 
C57BL/6 mice can only functionally express the I-A MHC-II molecule since the α-chain 
of I-E contains a deletion that precludes its expression [33]. When I-Aβ is knocked out, 
although MHC-II expression is drastically reduced, I-Aα still has the potential to pair 
with I-Eβ to create a mixed MHC-II molecule. Indeed, such hybrid heterodimers appear 
to be expressed in I-Aβ-/- mice (although not at detectable levels) [187, 188]. Overall, 
though the studies claim that their tested DP cells were MHC-naïve, it is possible that 
MHC molecules were expressed in the thymi of these mice (albeit at low levels) that 
could have influenced their conclusions. 
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 As previously discussed, during thymic development, a complete αβ TCR 
heterodimer is first paired and expressed at the DP thymocyte stage [59]. Upon 
expression, TCRs can be tested for their ability to interact with self-pMHC ligands on 
thymic epithelial cells and the cells bearing these TCRs can undergo selection. 
Importantly, since the TCRα locus becomes accessible for rearrangements to occur only 
at the DP stage, no formal selection of αβ TCRs occurs prior to this stage. Preventing 
expression of TCRα chains would therefore be sufficient to abrogate selection of αβ 
TCRs altogether.  
 The murine TCRα locus comprises TRAV genes, TRAJ genes, and a single TRAC 
gene [47]. As described earlier, rearrangements between the TRAV and TRAJ genes and 
incorporation of junctional diversity occur in the genome at the DNA level. The TRAC 
gene is instead fused to the rearrangement during RNA splicing. Of note, the TRAC 
gene requires one specific reading frame as the other two introduce premature stop 
codons and a severely truncated and unstable protein upon translation. Since the 
recombination machinery does not select for any particular reading frame, 
approximately 2/3 of the TCRα rearrangements in vivo yield non-productive proteins. 
The TRAC gene can also be specifically disrupted to ensure that all rearrangements 
yield a non-productive protein and several such mice have been described (referred to 
as TCRα-/- mice here) [157, 189]. In the thymi of these mice, DP thymocytes are 
developmentally arrested as they cannot express functional TCR αβ pairs on their 
surfaces and the cells never mature past the DP stage. Importantly, the cells continue to 
rearrange their TCRα loci and possess rearranged TCRα transcripts that produce 
unstable proteins due to the disrupted TRAC gene.  
 We avoided the pitfalls of the previous studies by obtaining our pre-selection 
TCR repertoire from TCRα-/- mice. Of interest to us is that the rearrangements in DP 
thymocytes from a TCRα-/- mouse had never been expressed and interrogated in vivo for 
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their ability to interact with any ligand. Consequently, these rearrangements would 
represent a true unselected TCR repertoire that had never engaged any ligand. The 
repertoire could in principle possess specificities for all sorts of ligands as the selection 
hypothesis would predict or be predisposed to recognize MHC, as predicted by the 
germline hypothesis. Therefore, expressing the TCRs from this source in our 
hybridomas and subsequently testing the hybridomas’ reactivities in different stimulation 
conditions would strictly be assessing the reactivity of an unselected TCR repertoire. 
 Upon cloning the 5 different TRAV libraries into the retroviral plasmids, we 
obtained a total of ~1.6x104 functional TCRα rearrangements. These sequences 
displayed some TRAJ gene usage biases but all TRAJ genes were represented, 
nonetheless. The CDR3 lengths for these sequences were relatively normally 
distributed with a peak centered at around 14 residues. Curiously, in a recent 
publication, deep sequencing was used to determine that the post-selected CDR3α 
lengths were shorter and centered at around 11-12 residues for both MHC-restricted 
and MHC-independent (obtained from QuadKO mice) TCRs [144]. Thus, TCRα chains 
with longer CDR3 regions are seemingly selected against by ligands. The basis for this is 
unclear, although the authors argued that longer CDR3 regions prevented the CDR1 
and CDR2 regions of the chain from appropriately contacting the MHC molecule. Yet, 
the CDR regions are all unstructured, flexible loops with the capacity to adapt their 
conformation based on their ligands upon ligation [190]. Another possibility is that 
TCRs with long CDR3 regions instead interact with the pMHC ligands too strongly and 
are removed from the repertoire due to negative selection. Determining the lengths of 
the CDR3α regions from DP CD69+ thymocytes, a population that has not completely 
undergone negative selection, may provide more insight into this matter. Alternatively, 
verifying CDR3α lengths from a Bim-/- thymus, which displays impaired negative selection 
[191], may shed some light as well. 
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 When we paired the TCRα libraries with the post-selected MHC-restricted 
TCRβ chains in the hybridomas, we observed strong reactivities towards pMHC ligands. 
Interestingly, the reactivities were primarily dependent on the nature of the TCRβ chain 
with a slight contribution from the TCRα chain. The 75-55β and the YAe5-62.8β chains 
both originate from TCRs that are highly peptide and MHC promiscuous. Replacing the 
TCRα chains with which they were originally paired with the TCRα libraries did not 
significantly affect their ability to remain promiscuous. Indeed, although both the 75-55 
TCR and the YAe5-62.8 TCR use TRAV6 rearrangements, hybridomas expressing either 
of the TCRβ chains paired to any of the TRAV libraries responded strongly to pMHC 
molecules. However, the responses were different when we assessed the reactivities of 
the hybridomas expressing the DO-11.10β paired to the various TRAV libraries. Unlike 
the two former TCRβ chains, the DO-11.10β originates from a TCR that has a defined 
specificity [27]. The only hybridomas that responded in an antigen presentation assay 
were those bearing the TRAV5 library, which, incidentally, is the same TRAV gene used 
by the original DO-11.10α chain. Thus, these data suggest that due to the nature of the 
DO-11.10β chain, only certain TCRα chains could promote reactivity while the more 
promiscuous 75-55β and YAe5-62.8β chains were more accommodating of the TCRα 
chains with which they paired to produce a reactivity. Importantly, all of the reactivities 
were largely pMHC-restricted, paralleling the reactivities of the TCRs from which the 
TCRβ chains were derived. Therefore, it appears that the TCRα chain to which the 
TCRβ chain is paired fine tunes the pMHC reactivity intrinsic to the TCRβ chain. 
 As discussed briefly, each of the three post-selected TCRβ chains tested in our 
experiments used a TRBV13-2 rearrangement. Consequently, the CDR1 and CDR2 
residues contacting the ligand were identical for all three TCRβ chains. However, the 
CDR3 residues were not equivalent. Since the CDR3 lengths for each of the chains are 
the same, the amino acid composition of the respective CDR3 regions must drive their 
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reactivity biases. Comparing the CDR3 sequences, the sequence identity is largely 
similar (Figure 3.14). Yet, in the middle of the loop (referred to as the FG loop of the 
CDR3) [144, 192], the 75-55β and YAe5-62.8β chains both possess bulky, hydrophobic 
residues whereas the DO-11.10β instead possesses small/polar residues.  
 Mutational studies involving the YAe5-62.8β chain demonstrated that although 
the chain is tolerant to most mutations in its CDR3 in order to maintain its reactivity, 
mutating the CDR3 tryptophan residue (W95) completely abrogates its reactivity [159]. 
The structure of the YAe5-62.8 TCR bound to the I-Ab/3K peptide complex 
corroborates this finding since many of the contacts made by the YAe5-62.8 CDR3β 
chain are due to this residue [156]. One could speculate that the broad cross-reactivity 
observed in such TCRs is because large residues dominate the interactions with their 
contacts, which could yield two consequences. First, the contributions by the other 
CDR3 residues are minimized. Second, the presence of the large residues makes the 
receptor more adaptable to changes in pMHC ligands because bulky residues continue 
to create contacts with the modified ligands. In TCRs with more restricted specificities, 
there is a greater distribution of labor by the smaller CDR3 residues, with each 
contributing to the overall interaction energy. Consequently, they are more sensitive to 
changes in their pMHC ligands because those may disrupt the contributions afforded by 
certain CDR3 residues, which have a larger comparative impact on the overall 
interaction [87]. Indeed, a similar hypothesis was put forward by the authors who 
solved the first TCR/pMHC complex structure [193].   
Such hypotheses are borne out by the finding in a recent publication that large 
hydrophobic residues within the CDR3 promote greater self-reactivity. Indeed, an in 
silico model also demonstrated that strongly interacting amino acids (such as those that 
are large and can create many contacts with pMHC ligands) are more prevalent in 

















Figure 3.14 Polyreactive TCRβ chains possess a hydrophobic doublet motif 
in their CDR3 loops. The CDR3 sequences for the 75-55β, the YAe5-62.8β, the DO-
11.10β, and the A11β (originating from a non-MHC-restricted TCR) are aligned. All 4 
TCRβ chains are TRBV13 rearrangements. Identical residues are highlighted in red. 
Positions highlighted in yellow are those implicated in determining extent of self-












Intriguingly, the TCRβ chain from the A11 TCR (specific for CD155) also possesses 
small, polar residues in its FG loop and displays strong specificity for its ligand [135]. 
Thus, it is possible that possessing small/polar residues within the CDR3β is a feature 
determining restricted specificity, irrespective of whether the specificity is directed 
towards pMHC or non-MHC ligands. 
 However, such CDR3β sequences are not common in the pre-selection 
repertoire. Instead, small/polar residues dominate the CDR3β regions (Figure 3.15). 
Upon further analysis of the sequences, it appears that the germline sequences code for 
residues that are small/polar by nature. One explanation for this observation could be 
that the germline sequences have been evolutionarily selected to avoid coding for 
residues that may provide strong self-reactivity. By doing so, the TCRs that arise from 
these sequences are less likely to interact strongly with self ligands and undergo negative 
selection. Additionally, this also mitigates the selection of TCRs that could become 
autoreactive in the periphery. The large hydrophobic residues are likely introduced by 
the TdT enzyme in the form of non-templated nucleotides. Since the number of codons 
coding for such residues is low (2 for F, 1 for W and 2 for Y, for example), TdT 
introducing the appropriate nucleotides that can then code for these residues is a low 
probability event. 
 The frequently rearranged TCRβ sequences we identified fit this paradigm as 
well. They lacked large, hydrophobic residues within their CDR3 regions. As might be 
predicted, when these chains were expressed in the hybridomas and paired to the 
TCRα libraries, there was little reactivity observed in antigen presentation assays. 
However, the few observed reactivities were largely directed at pMHC ligands. It is 
important to note that each of these sequences was isolated and tested without any 
prior knowledge of its specificity. Therefore, any of these sequences could in principle 
































Figure 3.15 Hydrophobic residues are rare in the FG loops of the pre-
selection CDR3β sequences. Sequence logos of TRBV13-2 CDR3 regions in the 
pre-selection repertoire obtained from TCRα-/- DP thymocytes. CDR3 amino acid 
lengths between 10 and 17 were analyzed. Logos were created using ggseqlogo in R 
[195].   
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pMHC ligands. Yet, we observed reactivities primarily directed only against pMHC 
molecules. When CD4 was added to the hybridomas, a greater proportion of 
hybridomas responded in a pMHC-restricted manner. Thus, it appears that hybridomas 
expressing TCRs that were not initially responding could now respond in the presence 
of CD4. Crucially, CD4 was not creating these reactivities but rather enhancing the 
otherwise weak reactivities. The unselected TCRs tested in our system possessed weak 
specificities for MHC that were further revealed by CD4, suggesting an inherent 
predisposition of TCRs for MHC molecules. Overall, our data suggest that TCRs did 
evolve to be biased for MHC molecules and that coreceptors evolved to further boost 
this bias.  
 In recent work by our group, we sequenced the TRBV13-2 rearrangements 
present in CD4+ αβ T cells from the spleen of C57BL/6 mice [111]. Intriguingly, all three 
of the frequently occurring rearrangements we identified in this study were also present 
in high numbers in the peripheral repertoire. Although the TCRα chains with which 
these TCRβ chains were paired is unknown, their presence in the periphery does 
indicate that they can be pMHC selected in vivo as well. When the amino acid 
frequencies at each position were determined for the CDR3β sequences, it was clear 
that bulky residues were largely excluded from the FG loops of the post-selected 
sequences (Figure 3.16). This further confirms selection favors the presence of weakly 
interacting amino acids in the CDR3 regions of TCRβ chains. In this manner, ligand 
cross-reactivity is mitigated in the peripheral repertoire. Additionally, during selection, 
coreceptors would boost the reactivities of TCRs with weakly interacting amino acids in 
their CDR3 regions to acceptable levels within DP thymocytes while boosting those 
with strongly interacting amino acids to levels favoring negative selection of the DP 


































Figure 3.16 Hydrophobic residues are rare in the FG loops of the post-
selection CDR3β sequences. Sequence logos of the TRBV13-2 CDR3 regions in the 
post-selection repertoire obtained from splenic CD4+ T cells from C57BL/6 mice. 




notion [87]. DP thymocytes in this mouse undergo negative selection, presumably due 
to strong self-reactivity engendered by the nature of the TCRβ chain. 
 Perhaps most surprisingly, pairing the unselected TCRα libraries with unselected 
TCRβ libraries in the hybridomas also produced observable reactivities. Once again, due 
to the manner in which the libraries were generated, there was no bias imposed for any 
pMHC or non-MHC specificities. The responses, though, were largely directed at 
pMHC ligands, supporting the idea that a germline bias exists for TCRs interacting with 
MHC molecules. Introducing CD4 further increased the proportion of hybridomas 
responding to pMHC molecules.         
 While our data strongly support the idea of a germline bias, it is possible that 
such a bias exists only within the context of murine TCRs interacting with murine MHC 
molecules. If so, then the germline hypothesis carries little weight since it is a species-
specific finding. Instead, when we generated chimeric TCRβ chains where the germline 
regions of murine TCRβ chains were replaced with germline regions of TCRs from 
different species, we continued to observe reactivities to pMHC ligands. These results 
highlight two important aspects of the germline hypothesis. First, although there is little 
sequence conservation between the TCR germline regions originating from the various 
species, the residues that are conserved remain crucial in promoting pMHC reactivities. 
Thus, one could speculate that these residues are just as important for pMHC 
recognition within each respective species and have been positively selected 
evolutionarily for this purpose. In fact, greater reactivity to murine MHC was observed 
when using TCRs bearing TRBV regions belonging to non-murine species. Thus, 
perhaps, some residues are evolutionarily conserved while others were selected within 
a species to prevent potent autoreactivity. Secondly, to ensure that the conserved TCR 
residues appropriately contact the MHC residues, it is likely that the orientation of the 
TCRs on the MHC molecules is also conserved. Structures solved of murine TCRs 
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bearing the same TRBV gene product suggest that these TCRs dock onto their cognate 
pMHC ligands in a diagonal manner, with a greater TCRα footprint present on the 
MHC-I α2 domain/MHC-II β-chain and a greater TCRβ footprint on the MHC-I α1 
domain/MHC-II α chain [190]. The conserved residues in the chimeric TCRs likely bias 
the TCRs to adopt a similar conformation. Two independent studies have recently 
identified human and murine TCRs that instead dock onto their pMHC ligands in a 
reverse orientation, suggesting that conserved residues are inconsequential and can be 
overcome by TCRs based on their specificities [196, 197]. Although we did not formally 
test the orientations in which the TCRs were interacting with their pMHC ligands, due 
to the high degree of species conservation of certain CDR2 residues, we speculate that 
TCRs have been evolutionarily selected to dock onto pMHC molecules in conserved 
modes. Future structural analyses of unselected TCRs should provide more information 























THE MOLECULAR BASES UNDERPINNING MHC-RESTRICTION 
In the periphery, αβ TCRs on mature T cells constantly interact with peptides 
presented by classical MHC molecules. These interactions serve two major purposes. 
First, signals provided by self-pMHC complexes appear to be required in ensuring the 
proper survival and maintenance of αβ T cells [198-201]. Tonic signaling, as this 
phenomenon has been termed, has now been shown to increase the peripheral fitness 
of both CD4+ and CD8+ αβ T cells. Second, αβ T cells use their TCRs to constantly 
survey the secondary lymphoid organs for the presence of any foreign antigens [202]. 
TCRs do so by interacting with the different pMHC complexes in these environments. 
In this manner, TCRs are exposed to a diverse collection of peptides in the context of 
MHC and have the potential to identify and react with any foreign peptides being 
presented by MHC molecules. Consequently, T cells bearing the relevant TCRs can 
become activated and mount an appropriate immune response against the invading 
pathogen.  
 One of the outstanding questions in basic T cell biology is why αβ TCRs on 
mature T cells are MHC-restricted. Cell-mediated immunity with specificity can be 
achieved without antigen receptors interacting with pMHC complexes. In jawless 
vertebrates (agnathans) such as lampreys and hagfish, diverse antigen receptors named 
variable lymphocyte receptors (VLRs) can be generated through a process of gene 
conversion [203]. Some of these antigen receptors (VLRB products) can be secreted 
much like antibodies while VLRA products are more reminiscent of cell-membrane 
associated TCRs. Since jawless vertebrates lack MHC genes, antigen recognition by 
VLRA molecules is thought to occur directly without the need for any processing [204]. 
Thus, despite being tethered to cell membranes, these antigen receptors recognize 
conformational epitopes on their antigens with high affinities just as antibodies do. Why 
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then do TCRs in jawed vertebrates require antigens to be processed and presented by 
MHC molecules? 
 Antibodies recognize native epitopes that are solvent exposed and display a 
slight bias for hydrophilic residues [205]. Due to this mode of antigen recognition, 
antibodies frequently interact with discontinuous epitopes on proteins that are 
composed of residues juxtaposed in tertiary structure despite being distant in primary 
structure. Additionally, depending on the structures of their targets, many potentially 
immunogenic epitopes may remain hidden to antibodies. Only upon being degraded by 
cellular proteasomes or endo-lysosomal proteases into linear peptides could previously 
hidden epitopes be revealed [39]. MHC molecules can now bind and present these 
linear epitopes to T cells bearing cognate TCRs. Thus, TCRs recognizing pMHC ligands 
allows the entire protein immunogen to be sampled in order to appropriately mount an 
immune response against pathogens. 
  Although MHC-restriction is well established, an ontogenic question remains – 
do TCRs possess an intrinsic predisposition to interact with pMHC ligands or do they 
instead possess multitude specificities but only the pMHC-restricted TCRs are 
selectively enriched in the mature population? Niels Jerne was the first to articulate 
both the question and an answer to the question [206]. He hypothesized that non-
intersecting evolution of TCR and MHC genes could eventually lead to loss of 
recognition of MHC molecules by TCRs as a consequence of independent assortment 
of the two sets of genes. Instead, a coevolution of the two would ensure that despite 
independent assortment of the genes, TCRs would continue to retain their specificity 
for MHC molecules. 
 Here, we experimentally addressed whether TCRs possessed an inherent bias to 
interact with MHC molecules. To do so, as discussed in Chapter II, we first generated 
a cell-based NFAT-induced GFP reporter system. The cells were TCR- T cell 
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hybridomas into which we could introduce various TCRs of interest. Since NFAT is a 
transcription factor downstream of TCR signaling, TCRs that were engaged by a ligand 
would initiate a signal cascade eventually leading to the activation of NFAT and the 
subsequent induction of GFP. We optimized this system to ensure a sensitive, robust, 
and accurate readout of stimulation. Importantly, stimulated cells could be individually 
identified. 
 Having established such a system, we generated and expressed unselected TCR 
libraries in the reporter cells. Next, as described in Chapter III, we tested the 
reactivities of the cells bearing over >105 unique antigen receptors against different 
APCs each expressing MHC molecules belonging to a certain haplotype. The responses 
observed, although limited, were largely directed at pMHC molecules. Interestingly, we 
observed that the amino acid composition of the CDR3β plays a dominant role in 
determining whether the αβ TCR interacted with pMHC ligands. The observed 
responses were significantly improved when the CD4 coreceptor was introduced into 
the cells as well. Lastly, we generated chimeric TCRs with V-regions originating from 
TCRs belonging to evolutionarily distant species. Yet, we continued to observe pMHC 
reactivity, suggesting perhaps that there is evolutionary conservation for MHC 
recognition by TCRs. 
 Compared to previous studies, our work used a true unselected TCR repertoire 
to appropriately answer the question. Yet, numerous other approaches can be 
undertaken to rigorously address the question. Here, some such approaches are 
outlined.  
4.1 Functional analyses of unselected TCR/pMHC interactions 
 In our study, we used the CD4 coreceptor to increase the reactivity of the TCR+ 
hybridomas to MHC. This raises an obvious question – would a similar boost in 
reactivity be observed if CD8 were to be introduced? Introducing CD8 in T cell 
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hybridomas expressing a pMHC-I-specific TCR has previously been demonstrated to 
enhance responses [207]. However, preliminary data in our experiments were largely 
inconclusive. We assessed extent of MHC reactivity in antigen presentation assays by 
comparing the proportion of GFP+ cells in a condition with isotype antibodies to the 
proportion of GFP+ cells in a condition with MHC blocking antibodies. The MHC-II 
blocking antibody (M5/114.15.2) we used was potent. However, upon introduction of 
CD8, the MHC-I blocking antibodies (28-8-6 for H-2b APCs and a combination of SF1-
1.1.1/34-5-8S for H-2d APCs) we used did not seem to influence the proportion of GFP+ 
cells (Figure 4.1). This could indicate one of two things – either the responses were 
not directed against MHC-I molecules or that the MHC-I blocking antibodies we added 
to the culture were not blocking the interactions. We find the latter proposition to be 
more likely. In some cases, CD8 did not improve the responses by the hybridomas at 
all, suggesting that perhaps there were few MHC-I-restricted TCRs in those repertoires. 
In other cases, introducing CD8 improved the hybridoma responses to APCs compared 
to the hybridomas lacking CD8. Since adding CD8 to the hybridomas allows only those 
hybridomas expressing pMHC-I-restricted TCRs to respond due to the ability of CD8 
to sequester Lck, this suggests that blocking interactions with MHC-I was likely 
inefficient.  
 Instead of relying on MHC blocking antibodies, we could have instead knocked 
out MHC-I molecules in our APCs using the CRISPR/Cas9 system. In particular, we 
could have disrupted β2m to prevent surface expression of any MHC-I proteins. 
However, this proved challenging. The CHB-2.4.4 cells were refractory to Cas9 activity 
and no knockout (as assessed by surface MHC-I levels) cells were observed. Identifying a 
cell line which can stimulate the hybridomas as efficiently as the CHB-2.4.4 cells and 









Figure 4.1 MHC-I blocking antibodies do not inhibit responses by CD8+ 
hybridomas.  Each of the TRAV libraries was independently expressed in CD8αβ+ 
hybridomas expressing the indicated TCRβ chains. The resulting hybridomas were then 
co-cultured with CHB-2.4.4 (top) or BALB/c MutuDC (bottom) APCs in the presence 
of isotype or MHC-I blocking antibodies and the proportion of GFP+ cells was assessed. 
The data from two independent experiments with two replicates per condition in a 
given experiment are summarized with red representing the isotype antibody condition 
and blue representing the MHC blocking antibody condition (error bars are mean ± 
s.d.). Multiple paired t-tests without post-test correction detected no significant 
















Such a cell line would then help resolve whether the observed responses in the CD8+ 
hybridomas were MHC-I-restricted or not. 
 TCRs interact with their cognate ligands using six unstructured CDR loops, with 
three belonging to the TCRα chain and three belonging to the TCRβ chain [6]. Four of 
the loops (CDR1/2 of α and β chains) are germline-encoded while the remaining two 
undergo somatic DNA recombination to generate substantial receptor diversity. Thus, if 
conserved interactions between TCRs and MHC molecules do exist for all TCRs, then 
the residues mediating such interactions must be located within the fixed CDR1 and 
CDR2 loops. 
 Several previous studies have focused on TCRs using the TRBV13 family of 
genes. These genes code for CDR2 regions that contain two tyrosine residues. 
TCR/pMHC complex structures solved of TRBV13-containing TCRs have identified a 
strong footprint by the tyrosine residues in CDR2β [141, 156, 179, 208]. Additionally, 
mutational analyses have determined that mutating the tyrosine residues abrogates TCR 
reactivities with their pMHC ligands [81, 143]. Although such residues have also been 
identified for a few other TRBV gene products, there has not been a comprehensive 
demonstration of which CDR1 and CDR2 residues are crucial for ligand recognition for 
all TRBV gene products. Since not all of them possess tyrosine residues in their CDR1/2 
loops, it is possible that individual genes may have evolved to code for different residues 
to help facilitate MHC recognition. 
 Aligning the CDR1 and CDR2 residues for each of the twenty-three functional 
TRBV proteins confirms that the sequences are largely different (Figure 4.2). Yet, 
there are some conserved elements. One residue that stands out is the histidine (H) 
residue in many mouse TRBV CDR1 loops. Not much is known about whether this 
residue plays a crucial role in MHC recognition. However, reactivity to the non-classical 




























Figure 4.2 Germline conservation of certain residues in murine TRBV 
genes. Residues in the CDR1 and CDR2 loops were aligned for each of the mouse 






TCR [209], perhaps hinting that this residue may play a similar role in αβ TCRs 
restricted to conventional MHC molecules. Some other residues at certain locations in 
the CDR2β (besides the tyrosine residues) are also shared across multiple genes but 
their relevance to MHC recognition is currently unknown.  
 Numerous TCRs with known specificities have now been curated and annotated 
[210]. Twenty-three different TCRs could be initially identified from this database with 
each one corresponding to one of the twenty-three TRBV gene products. In this 
manner, the contribution of each of the CDR1 and CDR2 residues could be tested and 
determined for each of the twenty-three TRBV gene products. Each of the loop 
residues could be mutated to an alanine residue and the resulting mutant TCRβ chains 
could be independently expressed in the NFAT-GFP reporter expressing hybridomas 
along with the corresponding TCRα chain. Subsequently, the various hybridomas could 
be cultured with APCs pulsed with the cognate peptide to assess which mutants 
abrogated GFP induction. Identifying residues that are required for proper TCR 
recognition of the pMHC complex could help resolve whether each TCR found a 
unique solution regarding how to interact with MHC molecules. Next, whether such 
mutations influence the ability of pre-selected TCRs to interact with their targets could 
also be tested. 
4.2 Structural analyses of unselected TCR/pMHC interactions 
 The vast majority of TCR/pMHC complex structures solved thus far 
demonstrate that TCRs use a conserved, diagonal docking angle to interact with their 
ligands [190, 211]. In this orientation, the TCRα chain tends to interact more with the 
MHC-II β-chain (MHC-I α2 domain) and the N-terminal end of the bound peptide while 
the TCRβ chain is positioned to interact better with the MHC-II α-chain (MHC-I α1 
domain) and the C-terminal end of the bound peptide. Such positioning is thought to 
ensure conserved residues present within the CDR1/CDR2 loops of the TCRα and 
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TCRβ chains interact with conserved residues on the MHC α-helices and orient the 
CDR3 loops to properly interact with the peptide [212]. Yet, not all TCRs appear to 
interact with their pMHC ligands in such an orientation. Some TCRs have been 
demonstrated to adopt a 180° reverse polarity yet remain MHC-restricted [196, 197]. 
Such an orientation would be in direct conflict with the germline hypothesis because 
conserved interactions between TCRs and MHC molecules would no longer be 
predicted to dictate MHC-restriction.  
 What is unclear is whether the unselected TCRs expressed in the responding 
hybridomas in this study were bound to MHC molecules in the canonical, reverse or a 
mix of both polarities. If these TCRs bound their pMHC ligands in exclusively one 
orientation, then conserved germline interactions could still be thought to dictate 
MHC-restriction (although our current thinking may require modification). However, if 
TCRs employ myriad docking solutions to interact with their targets, then the current 
established germline rules for MHC recognition are likely negligible. Although our data 
utilizing the species-chimeric TCR chains suggest a conserved mode of recognition 
(Figures 3.10 and 3.11), those results do not signify a formal demonstration. Solving 
the complex structures of the various TCRs bound to their targets would resolve this 
uncertainty. To do so, though, the appropriate ligand for each of the TCRs needs to be 
identified. 
 All of the experiments described in this study used hybridomas expressing 
various combinations of unselected TCRs. We then assessed the reactivities of these 
hybridomas when co-cultured with different APCs and determined that the responses 
were largely directed against MHC molecules. Yet, MHC molecules do not represent a 
singular ligand like CD5, CD19, or CD45. Instead, due to the peptides associated with 
the MHC molecules, any given MHC molecule could be vastly different (from a TCR’s 
perspective) than a neighboring MHC molecule. Different MHC alleles display biases for 
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the peptides they bind based on the allele-specific residues creating the peptide binding 
grooves [213, 214]. However, the biases MHC alleles display for peptides are more 
apparent for the anchor residues that interact with the peptide binding groove as 
opposed to the TCR-exposed residues, which are more variable. The variable residues 
are frequently the ones with which the TCR interacts and if the TCR makes sufficient 
contacts, then the TCR triggers a response in the T cell. Therefore, in order to 
determine how the TCRs are bound to their targets, it is crucial to first identify the 
peptides bound to the MHC molecules with which they interact. 
 Several methods have been utilized to identify the bound peptides that orphan 
TCRs recognize in the context of MHC. One method relies on cDNA libraries derived 
from APCs that can elicit responses in T cells bearing the orphan TCR [215]. 
Subsequently, the cDNA libraries are transfected by limiting dilution into APCs that do 
not endogenously stimulate the T cells and the APCs now capable of stimulating the T 
cells are enriched to reveal the stimulatory antigen. More contemporary approaches use 
combinatorial peptide libraries linked to specific MHC molecules and expressed in 
various cell lines [137, 216, 217]. Soluble orphan TCRs known to be restricted to that 
MHC molecule are used to screen the peptide library and eventually enrich for cells 
expressing pMHC complexes that could be the putative ligands [136, 218]. Some such 
libraries possess a peptide diversity >108 peptides, making this an attractive approach to 
identify the peptides with which the unselected TCRs interact.  
 Identifying the peptide specificities of a select few TCRs using this approach 
would accomplish two different tasks. First, the TCRs could now be complexed with 
their pMHC ligands to solve the ternary structures. This would allow us to determine 
whether unselected TCRs dock onto MHC using conserved residues or if instead they 
orient themselves in all sorts of manners. In parallel, solving the structure of the 
mCD155 specific TCR in complex with mCD155 [135] would also be important to 
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compare how non-MHC-restricted TCRs orient themselves onto their ligands. 
Secondly, the number of peptides isolated from the library with which any given TCR 
can interact would also be informative. In such experiments, it is common to obtain 
numerous peptide targets. Some have argued that the enriched peptides all share 
certain motifs of residues while others contend that they are instead enriched for 
peptides with all sorts residues with no uniting motif [137, 178]. If the screens with the 
unselected TCRs enrich for peptides with no common motif, that might serve as 
additional evidence for the germline hypothesis since the TCRs may rely more on their 
interactions with the MHC molecules rather than the composition of the peptides.  
4.3 Repertoire analyses of TCR/pMHC interactions 
 Understanding how TCRs recognize a given target is as crucial as understanding 
which TCRs recognize a given target. By identifying the repertoire of TCRs specific for 
any epitope, investigators can gain valuable insight into which TCRs participate in 
immune responses [219]. This can inform how/which/when vaccines are administered, 
the antigens likely to promote interactions with a diverse repertoire of TCRs and the 
cross-reactivity potential of various TCRs.  
 TCR repertoire analyses have taken many forms over the years. Initially, the 
analyses involved determining TRAV/TRBV genes expressed by T cells in a specific 
immune response [220, 221]. Such experiments allowed investigators to begin to grasp 
the nature of public vs. private TCRs [222, 223]. Private TCRs are those only found in 
one individual in an immune response while public TCRs are those found in multiple 
individuals, although the number of individuals in which a TCR is found in order to be 
considered public varies from study to study. Even though using these techniques did 
not provide sufficient resolution to determine the TCR sequences involved in the 
responses, it became clear that in some immune responses, responding T cells shared 
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TRAV/TRBV gene usage, suggesting that public responses may dominate in those 
instances. 
 Since the germline sequences of a given TRAV/TRBV protein were known, 
investigators began focusing on the nature of the CDR3 loops in TCRs to better gain an 
understanding of the repertoire. Spectratyping of CDR3 sequences provided even 
greater resolution of the TCR repertoire of a population of αβ T cells [224]. In this 
technique, the various CDR3 lengths present in the sample could be identified as a 
surrogate for the CDR3 sequences. Yet, this technique still did not provide any 
information regarding the CDR3 residues involved in interacting with the antigens. With 
the advent of next generation sequencing technologies, CDR3 sequencing of large 
samples could be conducted rapidly and in a cost-effective manner [225, 226]. Until 
recently, however, high-throughput sequencing was conducted primarily on one of the 
two TCR chains due to difficulties pairing the TCRα and TCRβ chains from a single cell. 
Advances in techniques have overcome this limitation as well, allowing for both the 
TCR chains out of a single cell to be identified in a high throughput manner [227-229]. 
 In the context of our study, we could sort and sequence the TCRα chains 
present in the GFP+ cells with a fixed TCRβ chain. The identified sequences could be 
compared across the various TCRβ chains tested as well as across the MHC haplotypes 
tested. It would also be interesting to compare the sequences from the CD4- GFP+ cells 
and the CD4+ GFP+ cells to identify the sequences unique to the CD4+ GFP+ cells. 
These would be sequences coding for TCRα chains that get engaged only in the 
presence of CD4. Furthermore, motif analysis could be conducted to determine 
whether a TCRα CDR3 signature exists within the sequences obtained from the 
responding cells. Lastly, sequencing the GFP+ cells expressing TCRα and TCRβ libraries 
would also be informative. By identifying the TCRβ sequences present in the responding 
population, we could verify whether they possess a hydrophobic doublet within their 
103 
 
CDR3 loops, since such a motif has been shown to promote greater self-reactivity 
[167].  
 A recent publication employed repertoire analysis to identify CDR3 motifs 
present in the pre-selected, post-selected/MHC-restricted and post-selected/MHC-
independent TCR repertoires [144]. Interestingly, the authors concluded that the TCR 
repertoires of all the various populations are not identical. Pre-selected TCRs are 
incredibly diverse with various CDR3 compositions and lengths being represented in the 
repertoire. However, upon MHC-mediated selection, TCRs possessing certain residues 
appear to be selectively excluded from the peripheral repertoire. Additionally, the 
CDR3 lengths of the post-selected MHC-restricted repertoire appear to be shorter 
compared to the CDR3 lengths in the pre-selected repertoire. Fewer such restrictions 
are imposed on the MHC-independent TCR repertoire. Overall, MHC molecules 
imprint their bias onto TCRs in determinable ways and these signatures can be 
identified by analyzing the repertoires. 
 It is important to note that in the mentioned study, the post-selected MHC-
restricted TCR repertoire was isolated from peripheral αβ T cells that had already 
survived negative selection. According to one study, approximately six times as many 
thymocytes undergo negative selection than positive selection [230] . Therefore, while 
it is important to gain a sense for the TCR repertoire of the surviving T cells, this does 
not paint a complete picture about the motifs present in MHC-restricted TCRs. The 
negatively selected thymocytes also expressed MHC-restricted TCRs and sequencing 
their repertoire might provide more information regarding the TCRs that pMHC ligands 
positively select. 
 Assessing the TCR repertoire of negatively selected thymocytes is not a trivial 
task. Thymocytes receiving strong TCR-mediated signals undergo apoptosis and are 
rapidly cleared by thymic macrophages [64, 231]. However, there are several 
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approaches to gain insight into their TCR repertoire. The activation marker CD69 has 
long been known to serve as a marker of positively selected thymocytes in the thymic 
cortex [232]. Determining the TCR repertoire of CD69+ thymocytes might reveal 
additional motifs that are missing in the peripheral TCR repertoire. Alternatively, since 
the pro-apoptotic protein Bim is important in promoting apoptosis in thymocytes that 
received strong signals, analyzing the DP CD69+ TCR repertoire from a Bim-/- might be 
even more informative [191, 230]. These thymocytes would be actively signaling yet 
unable to undergo efficient apoptosis. Indeed, there are approximately three times as 
many CD69+ thymocytes in a Bim-/- mouse, indicating that many TCR sequences which 
would have otherwise been removed from the repertoire could be obtained from such 
samples. 
 In our study, we identified that bulky, hydrophobic residues within the CDR3β 
increase the self-reactivity of hybridomas bearing such TCRs. However, sequencing data 
from the TRBV13-2 pre-selection repertoire indicate that TCRβ sequences with 
hydrophobic motifs occur infrequently. This could be largely attributed to two reasons. 
Firstly, the germline TRBV, TBRD, and TRBJ genes generally are biased against coding 
for large, aliphatic residues in the FG loop. Indeed, upon analyzing the sequences for all 
the genes in the murine TRB locus, it is evident that the genes primarily code for small 
and polar residues at the junctions (Figure 4.3). This is further evidenced when the 
TRB genes for other species are also analyzed, perhaps suggesting that there is an 
evolutionary selection for this observation (Figures 4.4-4.7). Thus, for large residues 
to be included in the final CDR3β region, they likely must be introduced by the 
template-independent TdT DNA polymerase. Secondly, the large, hydrophobic residues 
(F, W, and Y) are only 1- or 2-fold codon degenerate. Therefore, the likelihood of TdT 




























Figure 4.3 Germline contributions to the CDR3 by murine TRB genes. The 
three C-terminal TRBV residues, the five N-terminal TRBJ residues and all the TRBD 
residues in each of the three reading frames capable of contributing to the CDR3 are 
depicted for all TRB genes. Phenylalanine (F), tryptophan (W), and tyrosine (Y) residues 























Figure 4.4 Germline contributions to the CDR3 by dog TRB genes. The three 
C-terminal TRBV residues, the five N-terminal TRBJ residues and all the TRBD residues 
in each of the three reading frames capable of contributing to the CDR3 are depicted 
for all TRB genes. Phenylalanine (F), tryptophan (W), and tyrosine (Y) residues near the 























Figure 4.5 Germline contributions to the CDR3 by human TRB genes. The 
three C-terminal TRBV residues, the five N-terminal TRBJ residues and all the TRBD 
residues in each of the three reading frames capable of contributing to the CDR3 are 
depicted for all TRB genes. Phenylalanine (F), tryptophan (W), and tyrosine (Y) residues 

























Figure 4.6 Germline contributions to the CDR3 by rhesus monkey TRB 
genes. The three C-terminal TRBV residues, the five N-terminal TRBJ residues and all 
the TRBD residues in each of the three reading frames capable of contributing to the 
CDR3 are depicted for all TRB genes. Phenylalanine (F), tryptophan (W), and tyrosine 
(Y) residues near the FG loop are colored in red. Leucine (L) and isoleucine (I) residues 




























Figure 4.7 Germline contributions to the CDR3 by rainbow trout TRB 
genes. The three C-terminal TRBV residues, the five N-terminal TRBJ residues and all 
the TRBD residues in each of the three reading frames capable of contributing to the 
CDR3 are depicted for all TRB genes. Phenylalanine (F), tryptophan (W), and tyrosine 
(Y) residues near the FG loop are colored in red. Leucine (L) and isoleucine (I) residues 




 A mouse possessing a mutant TRBD gene could be generated to ensure that all 
three reading frames possess a residue capable of creating the hydrophobic motif 
(Figure 4.8). In this manner, it is likely that the FG loops for all CDR3β 
rearrangements involving this TRBD gene would each contain a large, hydrophobic 
residue. Subsequently, the TCRβ repertoire from the thymocytes of these mice could 
be sequenced to confirm whether such residues are responsible for increasing MHC-
reactivity. It is also possible that thymocytes expressing strongly self-reactive TCRs 
could undergo negative selection. To prevent this, the mutant mouse could be crossed 
to the Bim-/- mouse to impair negative selection and isolate the self-reactive sequences. 
Previous work has determined that the conserved tyrosine in the CDR2 region of 
TRBV13-2 is important for ligand recognition and not exclusively MHC recognition 
[135]. Creating such a mutant TRBD mouse would also address a similar idea and verify 
whether hydrophobic residues in the CDR3β are important for broader self-reactivity 
instead of exclusively MHC-reactivity.   
 A relatively high frequency of αβ T cells are known to express alloreactive TCRs. 
Alloreactivity is the ability of TCRs on certain T cells to recognize peptide/foreign MHC 
complexes [233]. The precursor frequency of alloreactive T cells is approximately 100-
1000x higher than the precursor frequency of T cells with TCRs specific for a given 
pMHC complex [234]. Thus, despite not having been educated in the thymus on a given 
MHC allele, these TCRs are still able to interact with such non-self MHC alleles. 
Alloreactivity is thought to provide further evidence for the germline hypothesis since 
conserved TCR/MHC promote such interactions irrespective of the specific MHC 
alleles involved. Structural data support this idea as well [153, 208]. Clinically, 
alloreactivity is important in the fields of transplantation to ensure that neither the 
donor nor recipient T cells mount immune responses against their allo-targets [235]. 


















Figure 4.8 A mutant TRBD gene capable of coding for a large, hydrophobic 
residue in the FG loop in each reading frame. The mutant TRBD DNA sequence 
is displayed in black. The resulting amino acid sequence for reading frames 1, 2 and 3 are 
displayed in pink, green, and blue, respectively. The large, hydrophobic residues are 









expresses MHC alleles of paternal origin that would be considered foreign by maternal 
T cells. Indeed, regulatory T cells (Tregs) that suppress immune responses are enriched at 
this interface and have been demonstrated to be specific for fetal antigens [236]. These 
Tregs persist for extended periods of time even after delivery and rapidly expand in 
subsequent pregnancies. Overall, alloreactivity has a biologically important role beyond 
transplantation. 
 To determine whether alloreactive T cells expressing TCRs bearing some of the 
signatures of cross-reactivity identified in this study, we could transfer peripheral αβ T 
cells from a C57BL/6 mouse into an irradiated mouse (to prevent host cells from 
responding to the transferred cells) expressing MHC molecules from a different 
haplotype. The transferred cells could also be transgenic for GFP in the Nr4a1 (coding 
for Nur77) locus, an immediate-early gene downstream of TCR signaling [237]. 
Consequently, any transferred T cells that are alloreactive would upregulate GFP and 
could be readily isolated. Their TCRs could then be sequenced and any recurring CDR3 
motifs could be identified. Such experiments could be conducted by transferring T cells 
into various mice each bearing a different MHC haplotype to produce an alloreactivity 
map and determine how the various CDR loop compositions contribute to 
alloreactivity. This could further deepen our understanding of the rules involved in TCR 
recognition of MHC molecules.     
4.4 Evolutionary analyses of TCR/pMHC interactions 
 The mouse species (Mus musculus) diverged from the frog (Xenopus laevis), shark 
(Heterodontus francisci), and trout (Oncorhynchus mykiss) approximately 350 million years 
ago, 470 million years ago, and 430 million years ago, respectively [238]. Despite 
hundreds of millions of years of divergent evolution, certain common features are 
maintained with TCRs across species. Furthermore, as demonstrated in both this and a 
previous study, these features also facilitate interspecies MHC recognition [143]. 
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However, what remains unclear is whether these conserved residues are required for 
intraspecies MHC recognition as well. If so, this would suggest an evolutionary 
conserved docking mode of TCR molecules onto MHC molecules, but this remains to 
be formally demonstrated. 
 Xenopus laevis has served as a great model organism to study the adaptive 
immune system [239]. Additionally, these organisms can be immunized in a variety of 
manners [240-243]. Although there is a paucity of serological reagents specific for frog 
immune cells, several effector lymphocytes can be identified with the available reagents 
[244]. By immunizing frogs with a known antigen, the responding CD4+ T cells could be 
identified using antigen-bound MHC-II tetramers. Although such tetramers do not 
currently exist, they can be rapidly produced since the sequences are known. 
Subsequently, the TCR sequences in the responding T cells could be isolated. At this 
juncture, since the TCR, the antigen, and the MHC molecule are all known, a structure 
could be solved for the ternary complex. Such structures would further elucidate which 
residues are involved in TCR recognition of pMHC and whether they are conserved 
across species. Moreover, whether TCRs use an evolutionarily established mode to 
dock onto MHC molecules would also be resolved. 
4.5 Conclusions 
 Protein-protein interactions (PPI) of all sorts of affinities have been described in 
the literature. Some interactions occur transiently with millimolar affinities and lifetimes 
lasting seconds while others are stronger and occur with affinities in the femtomolar 
range, which in essence could be considered permanent [245]. Residues at the interface 
of transient PPI tend to display greater sequence variance and evolve at a faster rate 
than those residues present at the interface of higher affinity PPI [246]. Thus, despite 
undergoing co-evolution for similar time scales, the goal for all PPI is not to exclusively 
generate high affinity interactions. Importantly, mutations in proteins that increase 
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affinity for their targets have to be weighed against their effects on protein functions to 
ensure that interactions are specific yet occur in spatiotemporally defined manners. 
 The interactions between the TCR and MHC molecules are more complicated 
than conventional PPI. Although a given TCR/pMHC complex in principle is not too 
different from other PPI, the complexity arises due to the sheer diversity of either 
protein that needs to be accommodated. TCRs need to interact with their target with 
sufficient energy to trigger a signal while simultaneously remaining flexible enough to 
accommodate the variability in their CDR3 loops, the allele/class of MHC molecule 
being recognized and the length and composition of the bound peptides. Conserved 
TCR germline residues alleviate this apparent paradox by biasing TCRs to interact with 
conserved regions of MHC molecules to provide a foundation upon which specific 
CDR3/peptide interactions can be built. Overall, TCR/MHC interactions balance the 
unpredictability of the CDR3 regions generated by recombination and the nature of the 
MHC-bound peptides by evolutionarily selecting for TCR germline residues that 




















MATERIALS AND METHODS 
5.1 Mice and lymphocyte isolation  
 C57BL/6 and TCRα-/- (002116) mice were purchased from Jackson Laboratories 
(Bar Harbor, Maine). Thymi were harvested from 6-10 week-old mice. Single-cell 
suspensions were prepared via manual disruption by using a syringe plunger. 
5.2 RNA isolation and library generation 
 DP thymoytes from TCRα-/- mice were purified by sorting using a FACSAria 
Fusion sorter (BD Biosciences). RNA was subsequently isolated using the RNeasy Micro 
kit (Qiagen, Inc.) and stored in TE buffer. The RNA was reverse transcribed using 
SuperScript III (Thermo Fisher Scientific). Subsequently, cDNA was provided as 
template to amplify TRAV5, TRAV6, TRAV7, TRAV9, TRAV14, and TRBV13-2 
rearrangements using forward primers annealing to the leader sequences for each gene 
and reverse primers annealing to the early coding regions of TRAC/TRBC (Figure 5.1). 
The forward and reverse primers contained engineered restriction enzyme sites for 
downstream cloning.  
5.3 TCRs and retroviral plasmids 
 MSCV-GFP retroviral plasmids encoding the B3K506α, the B3K506β, iNKTα, 75-
55β, the YAe5-62.8β, and the DO-11.10β chains were provided by the Gapin and 
Kappler/Marrack labs. The TCRβ chains were then independently subcloned into a 
MSCV-hNGFR (MSCVβ) plasmid containing the complete coding sequence of TRBC. 
The TCRα chains were independently subcloned into a MSCV plasmid (MSCVα) lacking 
any reporter and containing the complete coding sequence of TRAC. A MSCVα-Bcl2 
plasmid was also created by inserting Bcl2 downstream of the internal ribosomal entry 
site (IRES). The TRBV13-2 PCR generated library was cloned into the MSCVβ recipient 




Figure 5.1 Primers used in this study. The sequences for various primers used in 
this study. The restriction enzyme sites in each primer used for downstream cloning are 
highlighted in blue. For the TRBV13-2_3 QuikW F/R primers, the introduced mutation 







MSCVα recipient plasmid. The TRBV13-2_1β, TRBV13-2_3β, TRBV13-2_4β sequences 
were synthesized by GenScript and subsequently cloned into the MSCVβ recipient 
plasmid. The TRBV13-2_3Wβ plasmid was created via site-directed mutagenesis by 
using the TRBV13-2_3β plasmid as template with the QuikChange XL Site-Directed 
Mutagenesis kit (Agilent Technologies, Inc.). The CDR3 sequences for the TCR chains 
used in this study are listed in Figure 5.2. The species chimeric TCRβ chains bearing 
the frog, shark and trout TRBV regions with the DO-11.10β CDR3 were already 
available in the Gapin lab. The DO-11.10β CDR3 sequence was replaced with the 13-
2_3Wβ and the 13-2_4β CDR3 sequence using overlap extension primers. The resulting 
PCR products were then separately cloned into MSCVβ. The hCD4-pA-GFP-NFAT 
retroviral plasmid was a kind gift by Dr. Kenneth Murphy (Washington University, St. 
Louis, MO). mCD28, mCD8α, and mCD8β were independently cloned into a MSCV-
Thy1.1 recipient plasmid. High-affinity hCD4 was cloned into a MSCV-eBFP recipient 
plasmid. Lastly, murine CD3 WTdelta-F2A-gamma-T2A-epsilon-P2A-zeta pMIA II was a 
gift from Dr. Dario Vignali (Addgene plasmid # 52093; http://n2t.net/addgene:52093; 
RRID:Addgene_52093) [95]. 
5.4 Sequencing 
 The TRBV13 PCR products ampified using DP thymocytes from three 
independent TCRα-/- mice were sequenced on the Ion Torrent next generation 
sequencing platform. The TRAV plasmid libraries were sequenced on the Illumina 
NovaSeq 6000 sequencing platform. The resulting sequencing reads were then analyzed 
using in-house software. The TRAV library diversity plots were generated using the 
Tableau Public Desktop software. 
5.5 Retroviral packaging and virus production 
 The Phoenix packaging cell line was used to produce competent retrovirus. 
Phoenix cells were co-transfected with the retroviral plasmid and the pCL-Eco  
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Figure 5.2 CDR3 sequences for the TCR chains used in this study. A The 
TRBV, TRBJ and CDR3 sequences for all the TCRβ chains used. B The TRAV, TRAJ, 





















packaging plasmid using Lipofectamine 2000 (Thermo Fisher Scientific). Supernatants 
containing the retrovirus were collected 24 hours after transfection and filtered using a 
0.22μm filter.  
5.6 Cell lines, retroviral transductions and sorting 
 The 58 α-β- T cell hybridoma, the CHB-2.4.4 B-cell lymphoma cell line, and the 
HT-2 cell line were provided by the Gapin and Kappler/Marrack labs. The BALB/c 
MutuDC cell line was kindly provided by Dr. Hans Acha-Orbea (University of Lausanne, 
Switzerland). The CHB-2.4.4 cells were grown in S-MEM and the MutuDC cells were 
grown in IMDM. 
 Using the appropriate media to grow the 58 hybridomas was crucial to generate 
reproducible data. Although the cells grew in RPMI media, the cells needed to be grown 
in DMEM to be able to properly signal. The high glucose DMEM (Gibco) was 
supplemented with 10% FBS, β-mercaptoethanol (55 μM final concentration), 
GlutaMAX (Thermo Fisher Scientific), non-essential amino acids (Thermo Fisher 
Scientific), sodium pyruvate (Thermo Fisher Scientific) and pencillin/streptomycin 
(Thermo Fisher Scientific). Cells were maintained in culture at a concentration between 
5x104 mL-1 and 5x105 mL-1 to prevent overgrowth. Additionally, cells were propagated 
in culture for no more than 6 weeks to prevent genomic drifting of the cell line.  
 1x105 hybridomas were spinfected when the retroviruses were clonal while 
1x106 hybridomas were spinfected when the retroviruses were polyclonal. Spinfections 
were conducted in the presence of 16 μg mL-1 of polybrene. After 1-2 days of rest, the 
infected hybridomas were sorted using the FACSAria Fusion sorter for expression of 
either a surface marker or a fluorescent molecule depending on the molecules being 
overexpressed. For TCR transductions, the TCRβ chain was first transduced into the 
recipient hybridomas. After sorting hNGFR+ cells, the sorted cells were infected with 
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TCRα chain-containing retroviruses. Since the TCRα retroviruses did not contain a 
surrogate marker, the infected cells were sorted for surface expression of TCR.   
5.7 Hybridoma stimulations 
 For plate-coated antibody stimulations, αCD3 (145-2C11) and αCD28 (37.51) 
were added to individual wells in a flat-bottom 96-well microtiter plate at the indicated 
concentrations. The plate was then incubated at 37°C for 3 hours and then washed 
twice with 1x PBS. Subsequently, 3x104 hybridomas were added to each well in 250 μL 
of media.  
 In antigen presentation assays, 3x104 hybridomas were cultured with 3x105 CHB-
2.4.4 cells or 1x106 MutuDC cells, unless otherwise noted. In cases where hybridomas 
were stimulated using either the 3K peptide or the αGC lipid, the antigens were added 
directly to the co-culture. In isotype antibody conditions, a rat IgG2b, κ antibody 
(RTK4530, Biolegend) and a mouse IgG2a, κ antibody (MOPC-173, Biolegend) were 
each added to the culture at the outset of stimulation at a concentration of 15 μg mL-1. 
In MHC blocking antibody conditions, αI-Ab/I-Ad (M5/114.15.2) αKb/Db (28-8-6, 
Biolegend), αKd (SF1-1.1.1, Thermo Fisher Scientific), and αDd (34-5-8S, Novus 
Biologicals) were each added to the appropriate wells at the outset of stimulation at a 
concentration of 15 μg mL-1.  
 After 18-24 hours of stimulation, GFP induction in the hybridomas was 
determined using the BD LSRFortessa (BD Biosciences) flow cytometer. To determine 
the concentration of IL-2 in the culture supernatant by ELISA, IL-2 was captured using 
the JES6-1A12 antibody (Biolegend) and then sandwiched using the biotinylated JES6-
5H4 antibody. The complex was then incubated with horseradish peroxidase-conjugated 
streptavidin and detected by an OD450 reading on a spectrophotomter upon adding 
substrate. To determine the concentration of IL-2 in the culture supernatant by the HT-
2 assay, the culture was added directly to wells containing HT-2 cells and extent of cell 
121 
 
proliferation was determining by an OD570 reading on a spectrophotometer after 24 
hours.  
5.8 Antibodies 
 The following mAbs were used to stain cells in this study: from Biolegend, αCD4 
(GK1.5), αCD8α (53-6.7), αCD69 (H1.2F3), αCD24 (M1/69), αTCRβ (H57-597), and 
αhNGFR (ME20.4), αTRBV1 (B20.6), αTRBV2 (KT4-10), αTRBV4 (8.48), αTRBV12 
(MR9-4), αTRBV13 (MR5-2), αTRBV13-3 (1B3.3), αTRBV14 (MR12-4), αTRBV15 
(MR11-1), αTRBV16 (RR3-15), αTRBV17 (MR10-2), αTRBV19 (RR4-7), αTRBV26 (KJ25), 
αTRBV29 (TR310), and αTRBV31 (14-2).    
5.9 Data analysis 
 Flow cytometry data files were analyzed using the FlowJo software (Tree Star, 
Inc.) The samples were first gated on FSC-A by SSC-A, followed by gating to remove 
doublets (FSC-W by FSC-H) and lastly on mAmetrine+ cells (in the BV510 channel) to 
gate specifically on the hybridomas that possessed the CD3-subunit retroviral plasmid. 
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